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ABSTRACT 
In many organisms, the most fundamental event during embryogenesis is 
differentiating between germline cells and specialized somatic cells. In C. 
elegans, PIE-1 functions to protect the germline from somatic differentiation and 
appears to do so by blocking transcription and by preventing chromatin 
remodeling in the germline during early embryogenesis. Yet the molecular 
mechanisms by which PIE-1 specifies germline remain poorly understood. Our 
work shows that SUMOylation facilitates PIE-1-dependent germline maintenance 
and specification. In vivo SUMO purification in various CRISPR strains revealed 
that PIE-1 is SUMOylated at lysine 68 in the germline and that this SUMOylation 
is essential for forming NuRD complex and preserving HDA-1 activity. Moreover, 
HDA-1 SUMOylation is dependent on PIE-1 and enhanced by PIE-1 
SUMOylation, which is required for protecting germline integrity. Our results 
suggest the importance of SUMOylation in the germline maintenance and 
exemplify simultaneous SUMOylation of proteins in the same functional pathway.  
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PREFACE 
The CRISPR work presented in Chapter I has been previously published as Kim, 
H., Ishidate, T., Ghanta, K.S., Seth, M., Conte, D., Jr., Shirayama, M., and Mello, 
C.C. A co-CRISPR strategy for efficient genome editing in Caenorhabditis 
elegans. Genetics 197, 1069-1080 (2014). This paper was the result of the 
collaborative effort. I designed the experiment with Dr. Craig C. Mello and 
performed all the experimental works except a couple of things. Dr. Ishidate 
created the unc-22 sgRNA, a Co-CRISPR marker. Dr. Shirayama provided 
method sources. I wrote the manuscript with contributions from all authors. 
 
 All of the works presented in Chapter II were performed by me. Dr. Craig 
C. Mello guided the experimental design and data analysis. I am preparing the 
manuscript for publication now. 
 
The work presented in Chapter III is a preliminary body of work that 
explores another molecular mechanism of PIE-1 function. Dr. Craig C. Mello and 
I designed the experiments. I performed all of the works. Dr. Shirayama provided 
the idea for generation of the pie-1(R109L) mutant. Dr. Craig C. Mello and Dr. 
Shirayama guided data analysis.
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CHAPTER I: INTRODUCTION 
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Germline Specification 
As the precursor of gametes, germ cells contain all genetic and epigenetic 
information, and they function in transmitting this information from one generation 
to the next (Figure 1.1). Since this process is continuous, germ cells are 
considered to be immortal. In addition, germ cells are totipotent, having the 
potential to differentiate into any type of tissue. For example, the fertilized egg 
that is formed when a sperm fertilizes an oocyte produces all of the cells in an 
organism: these are the primordial germ cells that are the precursors of the germ 
cells and somatic cells that give rise to the rest of an organism (Figure 1.1). 
Protecting germ cell identity from somatic differentiation or mutation is, therefore, 
a crucial matter in all animals. The mechanisms that determine how the germline 
is distinguished from somatic tissues have been studied extensively in various 
model organisms. 
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Figure 1.1 Life cycle of the germ cells 
The life cycle of the germ cells is a continuous process, and the germ cells are immortal. 
A new life begins when a sperm fertilizes an oocyte and they together form a zygote. 
The zygote forms primordial germ cells that are the precursors of the gametes for the 
next generation and produces many differentiated somatic cells that give rise to the rest 
of the organism. The red dot represents germ cells.  
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Germline specification in mice, Drosophila, and C. elegans 
In mice, primordial germ cells (PGCs) are induced in the epiblast by bone 
morphogenetic protein (Bmp) signaling (Figure 1.2A) (Lawson et al., 1999; Ying 
et al., 2000). WNT signaling also contributes to PGC generation because wnt3 
mutants fail to induce PGC although BMP signaling is activated (Figure 1.2A) 
(Ohinata et al., 2009). For the subsequent maintenance of the germline lineage, 
three other transcription factors play essential roles in somatic transcriptional 
regulation (Magnusdottir et al., 2013): B-lymphocyte-induced maturation protein-
1 (Blimp1) directly represses somatic genes by binding to specific regulatory 
sequences (Ohinata et al., 2005; Vincent et al., 2005); PR domain-containing 
protein 14 (Prdm14) is required for the activation of pluripotency genes (Yamaji 
et al., 2008); and transcription factor AP-2 gamma (Tcfap2c) functions as a 
downstream effector of Blimp1 (Figure 1.2B) (Weber et al., 2010). PRDI-BF1, the 
human ortholog of mouse Blimp1, is known to repress transcription by binding 
and recruiting histone modification enzymes, such as histone deacetylase 
(HDAC) and histone H3 lysine methyltransferase G9a, to a transcription site 
(Gyory et al., 2004; Yu et al., 2000). Similarly, Blimp1 also interacts with Prmt5, 
an arginine-specific histone methyltransferase, which results in high levels of 
H2A/H4 R3 methylation to repress transcription (Ancelin et al., 2006). 
	 5	
  
Figure 1.2 Specification of germline cells in mice 
(A) PGCs are formed via BMP and WNT signaling in the epiblast. Both BMP and WNT 
signaling play a role in activating of PRDM1/BLMP1 and PRDM14. AP2γ is a 
downstream factor of PRDM1/BLMP1. (B) Roles of three key transcription factors in 
PGCs. Both PRDM1/BLMP1 and AP2γ together are required for repression of somatic 
genes and PRDM14 is responsible for activation of germ cell genes.  
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In Drosophila, PGCs are formed during oogenesis when Oskar, a germline 
determinant in germ granules, leads to germ/pole plasm assembly (Figure 1.3) 
(Ephrussi and Lehmann, 1992; Illmensee and Mahowald, 1974). The 
specification of the germline cells is facilitated by three maternally loaded factors, 
germ cell-less (gcl), polar granule component (pgc), and nanos (nos), to inhibit 
transcription in PGCs (Figure 1.3). Pgc is required for inhibition of carboxy-
terminal domain (CTD) Ser2 phosphorylation of RNA Pol II via the sequestration 
of positive transcription elongation factor b (P-TEFb) kinase in the germline 
(Hanyu-Nakamura et al., 2008). During the formation of PGCs, Gcl plays a role in 
transcriptional repression of a subset of somatic genes through unknown 
mechanisms (Leatherman et al., 2002). As a downstream effector of Pgc, Nos 
inhibits histone modification enzymes that are involved in transcriptional 
activation (Kobayashi et al., 1996; Sato et al., 2007). 
	 7	
 
Figure 1.3 Specification of germline cells in Drosophila 
In Drosophila, Oskar is responsible for germ plasm assembly in the oocyte. Three 
factors that are localized in germ cell nuclei, Gcl, Pgc, and Nos, are required for 
transcriptional repression. 
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In Caenorhabditis elegans, PGCs are established through a series of four 
asymmetric divisions of an embryo. The first asymmetric division of the zygote 
(P0) gives rise to a larger somatic blastomere (AB) and a smaller germline 
blastomere (P1). Asymmetric divisions continue until the formation of the P4 
germline blastomere, which is the precursor of the PGCs. Then, the P4 germline 
blastomere undergoes equal cell division to generate two PGCs, Z2 and Z3, 
which resume divisions to generate the entire germline once the first stage (L1) 
larvae start feeding (Figure 1.4). 
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Figure 1.4 Specification of germline cells in C. elegans 
In C. elegans, the adult gonad (indicated by red shading) contains many germ cells. 
These germ cells develop into gametes, oocytes and sperms, and they together form a 
fertilized egg denoted P0. P0 divides into one germ cell (P1) and one somatic cell. P1 
gives rise to P2 and its sister somatic cell. These divisions continue to occur until the P4 
blastomere generates two PGCs, Z2 and Z3. Once L1 is hatched, Z2 and Z3 resume 
divisions to proliferate germ cells, which lead to the entire germline in the adult. 
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During these asymmetric cleavages, cytoplasmic germ granules (called P-
granules) are segregated to each germline blastomere. P-granules contain many 
maternally loaded RNAs and RNA-binding proteins (Strome, 2005). Among these 
are vasa-related RNA helicases GLH1–4 and the RGG domain proteins PGL1/3 
that persist in P-granules at all developmental stages (Gruidl et al., 1996; 
Kawasaki et al., 2004; Kawasaki et al., 1998; Kuznicki et al., 2000).  pgl and glh 
mutants show severe defects in larvae germ cell proliferation and gamete 
formation but not in germline specification (Kawasaki et al., 2004; Kuznicki et al., 
2000; Spike et al., 2008). The contribution of P-granules to germline specification 
is, however, still inconclusive due to redundancy and a strong maternal effect 
(Wang and Seydoux, 2013).  
In C. elegans, three maternally loaded factors OMA-1, OMA-2 and PIE-1 
regulate transcriptional repression in the early germline lineage. OMA-1 and 
OMA-2 are cytoplasmic proteins expressed in oocytes and the very early 
embryo; thus, their functional studies of these proteins have focused on post-
transcriptional regulation for oocyte maturation, instead of transcriptional 
regulation for germline specification (Detwiler et al., 2001; Kaymak and Ryder, 
2013; Lin, 2003; Nishi and Lin, 2005). In addition to regulating oocyte mRNA 
expression, however, OMA-1 and OMA-2 also globally repress transcription in 
the early germline blastomeres, P0 and P1, where they bind and sequester to the 
cytoplasm TATA-binding protein associated factor-4 (TAF-4), an essential 
component for transcriptional initiation in the nucleus (Guven-Ozkan et al., 2008).    
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PIE-1 is a key regulator of germline specification, given that germline 
blastomeres in pie-1 mutants adopt somatic fates (Mello et al., 1992). In addition, 
PIE-1 is segregated to each germline blastomere during the first four embryonic 
cleavages and its nuclear localization correlates with the role of PIE-1 in the 
transcriptional repression of somatic differentiation (Mello et al., 1996). The 
molecular mechanisms by which PIE-1 functions as a transcriptional repressor to 
protect the germline lineage from somatic differentiation have been extensively 
studied.  
 
PIE-1 and transcriptional repression 
The pie-1 gene was first identified in a screen for maternal-effect lethal 
mutations, and pie-1 mutant embryos produce excess numbers of pharyngeal 
and intestinal cells due to transformation of the germline blastomere P2 into a 
somatic blastomere, like its sister EMS (Mello et al., 1992). PIE-1 protein 
contains two CCCH zinc finger motifs and segregates with each germline 
blastomere (Mello et al., 1996). Nuclear localization of PIE-1 in the germline 
blastomeres has raised the possibility that PIE-1 might regulate transcription to 
repress somatic fates in the germline lineage. For example, one known factor 
regulated by PIE-1 is the SKN-1 transcription factor that is required for somatic 
differentiation but is present in both the germline blastomere P2 and the somatic 
blastomere EMS (Bowerman et al., 1993). In wild-type embryos, SKN-1 activity is 
thought to be down-regulated by PIE-1 to protect the germline lineage in P2, 
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because SKN-1 drives germline blastomere differentiation into somatic tissues in 
pie-1 mutants (Mello et al., 1992). Newly transcribed RNAs and CTD Ser2 
phosphorylation of Pol II are detected in both germline and somatic blastomeres 
in pie-1 mutants, whereas they are detected only in somatic blastomeres in wild-
type embryos (Seydoux and Dunn, 1997; Seydoux et al., 1996). Studies in a 
vertebrate cell culture assay suggested that PIE-1 functions as a transcriptional 
repressor using a specific repression sequence YAPMAPT on the C-terminus of 
PIE-1 (Batchelder et al., 1999). This sequence resembles the Pol II CTD 
heptapeptide repeat (YSPTSPS) sequence where Ser2 is phosphorylated during 
transcriptional elongation and Ser5 is phosphorylated during initiation (Figure 
1.5) (Batchelder et al., 1999; Zaborowska et al., 2016). Therefore, the YAPMAPT 
sequence competitively targets a Pol II CTD-binding complex to block 
transcription (Figure 1.5) (Batchelder et al., 1999). PIE-1 (DAQMEQT) 
transgenes with nonconservative mutations of the YAPMAPT motif eliminate 
transcriptional repression and significantly reduce the frequency of pie-1 rescue 
compared to the wild-type transgene (Batchelder et al., 1999). The YAPMAPT 
motif binds to Cyclin T, a regulatory subunit of P-TEFb, to inhibit Pol II elongation 
(Figure 1.5), whereas PIE-1 (DAQMEQT) does not (Zhang et al., 2003). A 
subsequent study of the YAPMAPT motif was performed in C. elegans using low-
copy integrated transgenic lines generated by ballistic transformation (Praitis et 
al., 2001). The results showed that the YAPMAPT is sufficient to inhibit Ser2 
phosphorylation, but not Ser5 phosphorylation (Ghosh and Seydoux, 2008). 
	 13	
Thus, PIE-1 (DAQMEQT) still has the ability to inhibit transcription like the wild-
type, which suggests PIE-1 regulates Ser5 phosphorylation by interacting with 
other components of the transcriptional machinery (Ghosh and Seydoux, 2008). 
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Figure 1.5 PIE-1 represses transcription in the germline blastomeres  
PIE-1 contains the YAPMAPT sequence that resembles the sequence YSPTSPS of the 
pol II CTD where Ser2 is phosphorylated during transcriptional elongation and Ser5 is 
phosphorylated during initiation. The YAPMAPT sequence competitively binds to 
CyclinT, the subunit of P-TEFb that is required for Ser2 phosphorylation, and blocks P-
TEFb recruitment to pol II CTD. PIE-1 also blocks Ser5 phosphorylation by an unknown 
mechanism. 
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PIE-1 and chromatin regulation 
PIE-1 protein begins to disappear immediately after the birth of Z2 and Z3. At this 
time, Z2 and Z3 show a transiently active chromatin state, and then revert to and 
retain the repressive chromatin state until they resume cell divisions at the L1 
larval stage (Furuhashi et al., 2010; Schaner et al., 2003). These specified-
dynamic chromatin states in PGCs depend on MES chromatin regulators: MES-
2, MES-3, MES-4 and MES-6. mes genes were identified from a screen for 
maternal effect sterility (Capowski et al., 1991), and even though they have a 
similar mutant phenotype, MES-4 functions differently from the others (Bender et 
al., 2004; Bender et al., 2006; Fong et al., 2002; Xu et al., 2001). For example, 
MES-2, MES-3, and MES-6 methylate Lys27 of histone H3, a repressive 
chromatin mark (Bender et al., 2004; Xu et al., 2001), whereas MES-4 
methylates Lys 36 of histone H3, an active or potentially active chromatin mark 
(Bender et al., 2006; Fong et al., 2002; Furuhashi et al., 2010; Rechtsteiner et al., 
2010). In embryos, MES-4 is present in all blastomeres until the 100-cell stage, 
but its expression level is diminished in somatic blastomeres except in Z2 and Z3 
(Fong et al., 2002). Given that MES-4 plays a role in establishing an active or 
potentially active transcription mark, MES-4 activity seems to be regulated in 
somatic blastomeres to preserve the somatic fates and prevent germline 
potential. Genetic studies suggest that chromatin regulators in the synthetic 
multivulva B pathway antagonize MES-4 activity (Unhavaithaya et al., 2002; 
Wang et al., 2005). Among these is MEP-1, a Krüppel-class zinc-finger protein 
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(Belfiore et al., 2002) that interacts with two subunits of the nucleosome 
remodeling and histone deacetylase (NuRD) complex (Unhavaithaya et al., 
2002): LET-418, a homolog of mammalian ATP-dependent nucleosome 
remodeling factor Mi-2 (von Zelewsky et al., 2000) and HDA-1, a homolog of 
mammalian histone deacetylase HDAC-1(Shi and Mello, 1998). PIE-1 interacts 
with MEP-1 and the NuRD complex in embryos to repress NuRD complex-
mediated chromatin remodeling, thereby protecting a germline-specific chromatin 
state that is established by MES proteins (Unhavaithaya et al., 2002).  
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SUMOylation 
SUMOylation is a post-translational modification that covalently and reversibly 
attaches small ubiquitin-like modifier (SUMO) to lysine residues of protein 
substrates. SUMOylation mainly occurs on a consensus SUMO acceptor site, 
consisting of the sequence ψKXE, where ψ represents a hydrophobic amino acid 
and X is any amino acid (Rodriguez et al., 2001), although a non-consensus 
motif also can be modified by SUMO (Tammsalu et al., 2014). In addition, not all 
proteins containing the consensus SUMO sequence are modified by SUMO. 
SUMOylation requires an enzymatic cascade involving E1-activating enzyme 
(Aos/Uba2p in yeasts), E2-conjugating enzyme (ubiquitin-like conjugating 
enzyme 9, Ubc9), and E3 ligase (Gareau and Lima, 2010). Ubc9 is a single 
SUMO E2 enzyme and has a unique ability to recognize and conjugate even 
without SUMO E3 ligase, although SUMO E3 ligases facilitate SUMO 
conjugation to a substrate (Hoeller et al., 2007; Kerscher et al., 2006). 
SUMOylation is a reversible modification because the conjugated SUMO is 
deconjugated from substrates by SUMO-specific proteases and free SUMO can 
be recycled in another round of SUMOylation (Gareau and Lima, 2010).  
The reversible SUMOylation cycle and the enzymes required for the 
SUMOylation pathway are conserved in C. elegans. In C. elegans, SUMO is 
encoded by a single gene smo-1, whereas four SUMO genes have been 
identified in the vertebrates (Guo et al., 2004; Melchior, 2000). The ubc-9 gene 
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encodes a SUMO E2 conjugating enzyme (Jones et al., 2002) and gei-17 
encodes a Siz/PIAS-type SUMO E3 ligase (Holway et al., 2005).  
Unlike ubiquitination that leads to protein degradation, SUMOylation 
regulates protein functions for diverse biological processes including 
transcription, cell cycle progression, and DNA repair (Hay, 2005). For example, 
SUMO-modified transcription factors change their cellular localization, stability, or 
binding partners to affect transcriptional activity (Gill, 2005; Hay, 2005). Although 
many important biological functions require SUMOylation, identification of SUMO 
target proteins in vivo is challenging because the abundance of a particular 
protein that is SUMOylated at steady state is relatively very low compared to the 
total pool of the protein (usually less than 5%) and many SUMO-specific 
proteases actively remove SUMO from substrates. However, it is notable that 
even a small portion of SUMO-modified protein can cause a dramatic effect 
(Geiss-Friedlander and Melchior, 2007; Hay, 2005). In addition, a defect in 
SUMOylation of a single substrate shows a very mild phenotype in most cases, 
but results in strong defects in a few cases (Sarangi and Zhao, 2015).    
 
SUMOylation and transcriptional repression 
Although SUMOylation of a transcription factor can cause transcriptional 
activation, it usually leads to transcriptional repression by either recruiting 
repressors with chromatin remodeling activity or facilitating assembly of a 
transcriptional repression complex (Geiss-Friedlander and Melchior, 2007; Gill, 
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2005; Hay, 2005). HDAC recruitment is directly or indirectly involved in 
SUMOylation-mediated chromatin remodeling (Gill, 2005). For example, in C. 
elegans, SUMOylated LIN-1 represses transcription by recruiting the NuRD 
complex, which leads to inhibition of 1° vulval cell fate (Leight et al., 2005). 
 
SUMOylation and DNA repair  
Another essential biological function mediated by SUMOylation is DNA repair. 
Many DNA repair proteins are modified by SUMO, which affects their DNA 
binding affinity, promotes protein–protein interaction, and affects their protein 
stability to tightly control DNA damage repair and response (Sarangi and Zhao, 
2015). Thymine DNA glycosylase (TDG), an essential repair enzyme for base 
excision repair, is a well-known SUMO substrate. TDG SUMOylation allows 
recycling of TDG: For example, TDG SUMOylation leads to release of TDG from 
its DNA substrate by reducing DNA affinity and then SUMO-specific proteases 
deconjugate the released TDG, which is free again to bind to mismatches in 
other DNA substrates (Hardeland et al., 2002). In C. elegans, depletion of ubc-9 
and gei-17 using RNA-mediated interference (RNAi) results in high sensitivity to 
DNA damage and both smo-1 and ubc-9 null mutants fail to repair DNA breaks 
that occur in mitotically dividing nuclei in the premeiotic distal tip, suggesting 
SUMOylation plays an important role in the DNA damage repair and response 
(Boulton et al., 2004; Holway et al., 2006; Reichman et al., 2018). One 
subsequent study of gei-17 suggested that GEI-17 leads to SUMOylation of 
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translesion synthesis (TLS) DNA polymerase POLH-1, and SUMOylated POLH-1 
is protected from degradation before it can perform its function in response to 
DNA damage (Kim and Michael, 2008). Recently, ZTF-8 was identified as a 
SUMO target protein involved in DNA repair pathways in the germline (Kim and 
Colaiacovo, 2015). ZTF-8, a homolog of mammalian RHINO that interacts with 
the Rad9-Rad1-Hus1 complex, is required for DNA double strand break repair 
and DNA damage-checkpoint–mediated apoptosis (Kim and Colaiacovo, 2014). 
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A Co-CRISPR Strategy for Efficient Genome Editing in C. elegans 
This work has been published previously 
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Abstract 
Genome editing based on CRISPR (clustered regularly interspaced short 
palindromic repeats)-associated nuclease (Cas9) has been successfully applied 
in dozens of diverse plant and animal species including the nematode 
Caenorhabditis elegans. The rapid life-cycle and easy access to the ovary by 
microinjection make C. elegans an ideal organism both for applying CRISPR-
Cas9 genome editing technology and for optimizing genome-editing protocols. 
Here we report efficient and straightforward CRISPR-Cas9 genome editing 
methods for C. elegans, including a Co-CRISPR strategy that facilitates detection 
of genome-editing events.  We describe methods for detecting homologous 
recombination (HR) events, including direct screening methods as well as new 
selection/counter-selection strategies. Our findings reveal a surprisingly high 
frequency of HR-mediated gene conversion, making it possible to rapidly and 
precisely edit the C. elegans genome both with and without the use of co-
inserted marker genes. 
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Introduction 
Sequence-specific immunity mechanisms such as RNA interference (Grishok 
and Mello, 2002; Hannon, 2002; Voinnet, 2001; Zamore, 2001) and CRISPR-
Cas9 (Bhaya et al., 2011; Horvath and Barrangou, 2010; Terns and Terns, 2011; 
Wiedenheft et al., 2012) provide sophisticated cellular defense against invasive 
nucleic acids.  Understanding how these defense systems work has enabled 
researchers to re-direct them at cellular targets, providing powerful tools for 
manipulating both gene expression and the cellular genome itself. The CRISPR-
Cas9 system is a bacterial anti-viral mechanism that captures fragments of viral 
DNA in specialized genomic regions for re-expression as small guide RNAs 
(sgRNAs) (Bhaya et al., 2011; Terns and Terns, 2011; Wiedenheft et al., 2012). 
In bacterial cells Cas9-sgRNA complexes provide acquired immunity against viral 
pathogens (Bhaya et al., 2011; Terns and Terns, 2011; Wiedenheft et al., 2012). 
When co-expressed along with an artificial sgRNA designed to target a cellular 
gene, the Cas9 nuclease has been shown to efficiently direct the formation of 
double-strand breaks at the corresponding target locus (Jinek et al., 2012). 
Remarkably, this mechanism works efficiently even within the context of 
eukaryotic chromatin (Gilbert et al., 2013). Genome editing using CRISPR-Cas9 
has recently been demonstrated in numerous organisms, providing a powerful 
new tool with rapidly growing–if not infinite–potential for diverse biological 
applications (Bassett et al., 2013; Chang et al., 2013; Cho et al., 2013a; Cong et 
al., 2013; Dicarlo et al., 2013; Dickinson et al., 2013; Feng et al., 2014; Feng et 
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al., 2013; Friedland et al., 2013; Gratz et al., 2013; Jiang et al., 2013; Ma et al., 
2014; Mali et al., 2013b; Wang et al., 2013; Yu et al., 2014; Zhou et al., 2014).  
The CRISPR-Cas9 system has also been successfully applied to C. 
elegans. Methods that have been used to express Cas9 include mRNA injection 
and transgene-driven expression from a constitutive or an inducible promoter 
(Chen et al., 2013; Chiu et al., 2013; Cho et al., 2013b; Dickinson et al., 2013; 
Friedland et al., 2013; Katic and Grosshans, 2013; Lo et al., 2013; Tzur et al., 
2013; Waaijers et al., 2013; Zhao et al., 2014). The U6 promoter has been used 
to drive sgRNA expression (Chiu et al., 2013; Dickinson et al., 2013; Friedland et 
al., 2013; Katic and Grosshans, 2013; Waaijers et al., 2013). The system has 
been used widely to produce small insertions and deletions (indels) that shift the 
reading frame of the target gene, often resulting in premature termination of 
translation and loss-of-function phenotypes (Chiu et al., 2013; Cho et al., 2013b; 
Friedland et al., 2013; Lo et al., 2013; Waaijers et al., 2013). In addition, single-
stranded oligonucleotides have been used as donor molecules to precisely alter 
a target gene through homologous recombination (HR) (Zhao et al., 2014), and a 
selection scheme has been developed that allows the HR-mediated insertion of 
large sequence tags such as GFP (Chen et al., 2013; Dickinson et al., 2013; Tzur 
et al., 2013).  
Despite these important advances, current CRISPR protocols for inducing 
indels and HR events in C. elegans could benefit from refinement. For example, 
different sgRNAs targeting the same gene can result in substantially variable 
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DNA cleavage efficiencies (Bassett et al., 2013; Chen et al., 2013; Wang et al., 
2014); thus, identifying active sgRNAs can be time consuming and costly. In this 
study, we investigate several strategies to streamline CRISPR-Cas9-mediated 
genome editing in C. elegans. We describe a co-CRISPR strategy that can 
facilitate the identification of functional sgRNAs, and can enrich for transgenic 
animals carrying an HR event. We show that HR events can be identified without 
the need for selection at a rate of approximately 1% to as high as 10% of F1 
transgenic animals scored. This high frequency allows HR events to be identified 
by directly scoring for GFP expression, or by polymerase chain reaction (PCR) 
screening to detect HR-induced DNA polymorphisms. Direct screening allows 
precise genome alterations that minimize the footprint of DNA alterations, such 
as inserted selectable markers, at the target locus. However in some cases, such 
as whole-gene deletion assays that may induce lethality, selection can be useful 
for both identifying and maintaining HR events. We therefore describe a straight-
forward selection/counter-selection protocol that facilitates recovery of HR events 
where having a marker inserted at the target site might be tolerated or useful. 
Together the findings presented here take much of the guesswork out of using 
the CRISPR-Cas9 system in C. elegans, and the co-CRISPR strategy employed 
here may also prove useful in other organisms. 
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Materials and Methods 
Genetics 
All strains in this study were derived in the Bristol N2 background and maintained 
on nematode growth medium (NGM) plates seeded with OP50 (Brenner, 1974).  
 
Selection of sgRNA target sequences 
We manually searched for target sequences consisting of G(N)19NGG (Friedland 
et al., 2013; Wiedenheft et al., 2012) near the desired mutation site. For HR-
mediated repair experiments such as gfp knock-in and introduction of point 
mutation, we selected the target sequences where it was possible to introduce a 
silent mutation in the PAM site. Target sequences are listed in Table 1.1.  
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Table 1.1 Summary of sgRNAs sequences and their efficiency 
Name Sequence S/AS % efficiency 
avr-14 no.1 GAATATTGAAAGACTATGAT(TGG) S 10 
avr-14 no.2 GATTGGAGAGTTAGACCACG(TGG) S 20 
avr-15 no.9 GCAGAAAATGAATGTCATAC(AGG) AS HIGH 
avr-15 no.10 GTTTGCAATATAAGTCACCC(AGG) AS HIGH 
unc-22 no.2 GAACCCGTTGCCGAATACAC(AGG) S 5 
unc-22 no.9 GCCTTTGCTTCGATTTTCTT(TGG) AS 0 
unc-4 no.1 GTTATCGTCATCCGGTGACG(TGG) AS 10 
rde-3 no.3 GAATTTGAGCTTGAACGAGC(TGG) AS LOW 
rde-3 no.4 GTCGATACTTCAAAATTAAT(TGG) AS LOW 
lon-2 no.1 GGGAAACTATACCCTCACTG(TGG) S 30 
dpy-11 no.2 GCAAGGATCTTCAAAAAGCA(CGG) S 
0.4 
dpy-11 no.4 GATGCTTGTAGTCTGGAACT(GGG) AS 
unc-32 no.1 GATAGGAAGCATCAGATTGA(AGG) AS 
0 
unc-32 no.2 GTTGCTGAACTGGGAGAGCT(CGG) S 
bli-2 no.1 GGATTTGCTGCTACTGAATC(CGG) AS 
0 
bli-2 no.2 GATGGACGGGATGGTAGAGA(TGG) S 
dpy-5 no.2 GTCGGATTCGGCGCTGCATG(CGG) S 
0 
dpy-5 no.3 GGTTTCCTGGAGCTCCGGCT(GGG) AS 
ben-1 no.3 GGATATCACTTCCCAGAACT(TGG) AS 
0 
ben-1 no.5 GGGAGAAAGTGATTTGCAGT(TGG) S 
pie-1 a GGCTCAGATTGACGAGGCGC(CGG) S 24 
pie-1 b GCTGAGAGAAGAATCCATCG(GGG) AS 15 
pie-1 c GGACAAAGAGAGGGGGTGAG(TGG) AS 7.5 
pie-1 d GTTGAGTGCAGCCATTTGCT(CGG) AS 5 
smo-1 a GCCGATGATGCAGCTCAAGC(AGG) S LOW 
smo-1 b GTGCACTTCCGTGTAAAGTA(TGG) S HIGH 
smo-1 c GTCTACCAAGAGCAGCTGGG(CGG) S HIGH 
smo-1 d GTATCTCAGTGGAAAAGGGA(TGG) S HIGH 
vet-2 GTTGGATCATAGGATACCGG(TGG) AS 38 
C35E7.6 GGGCACCATACCGAGTGATG(GGG) AS 100 
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Preparation of sgRNA constructs 
We replaced the unc-119 target sequence in pU6::unc-119 sgRNA vector 
(Friedland et al., 2013) with the desired target sequence using overlap extension 
PCR. The pU6::unc-119 sgRNA vector was diluted to 2 ng/µl and used as a 
template to generate two overlapping fragments. The first was amplified using 
the primers CMo16428 and sgRNA R, resulting in the U6 promoter fused to the 
GN19 target sequence (U6p::GN19). The second was amplified using the primers 
CMo16429 and sgRNA F, resulting in the GN19 target sequence fused to the 
sgRNA scaffold and U6 3’UTR. These two PCR products were mixed together, 
diluted 1:50, and used as a template for a PCR reaction with primers CMo16428 
and CMo16429. The resulting pU6::target sequence::sgRNA scaffold::U6 3’UTR 
fusion products were gel-purified and inserted into the pCRtm-Blunt II-TOPO® 
vector (Invitrogen, cat. no. K2800-20). We used iProofTM high-fidelity DNA 
polymerase (Bio-Rad, cat. no. 172-5300) in all PCR reactions above to minimize 
errors of PCR amplification, and all the constructs were confirmed by DNA 
sequencing. Primers sequences are listed in Table 1.2. 
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Table 1.2 Summary of primer sequences for sgRNA plasmid generation 
Name Sequence 
CMO16428 TGAATTCCTCCAAGAACTCG 
CMO16429 AAGCTTCACAGCCGACTATG 
sgRNA_F G(N)19GTTTTAGAGCTAGAAATAGC 
avr-14 sgRNA_F GATTGGAGAGTTAGACCACGGTTTTAGAGCTAGAAATAGC 
avr-15 sgRNA_F GTTTGCAATATAAGTCACCCGTTTTAGAGCTAGAAATAGC 
unc-22 sgRNA_F GAACCCGTTGCCGAATACACGTTTTAGAGCTAGAAATAGC 
pie-1 a sgRNA_F GGCTCAGATTGACGAGGCGCGTTTTAGAGCTAGAAATAGC 
pie-1 b sgRNA_F GCTGAGAGAAGAATCCATCGGTTTTAGAGCTAGAAATAGC 
pie-1 c sgRNA_F GGACAAAGAGAGGGGGTGAGGTTTTAGAGCTAGAAATAGC 
smo-1 sgRNA_F GTATCTCAGTGGAAAAGGGAGTTTTAGAGCTAGAAATAGC 
vet-2 sgRNA_F GTTGGATCATAGGATACCGGGTTTTAGAGCTAGAAATAGC 
sgRNA_R (N)19CAAACATTTAGATTTGCAATTC 
avr-14 sgRNA_R CGTGGTCTAACTCTCCAATCCAAACATTTAGATTTGCAATTC 
avr-15 sgRNA_R GGGTGACTTATATTGCAAACCAAACATTTAGATTTGCAATTC 
unc-22 sgRNA_R GTGTATTCGGCAACGGGTTCCAAACATTTAGATTTGCAATTC 
pie-1 a sgRNA_R GCGCCTCGTCAATCTGAGCCCAAACATTTAGATTTGCAATTC 
pie-1 b sgRNA_R CGATGGATTCTTCTCTCAGCCAAACATTTAGATTTGCAATTC 
pie-1 c sgRNA_R CTCACCCCCTCTCTTTGTCCCAAACATTTAGATTTGCAATTC 
smo-1 sgRNA_R TCCCTTTTCCACTGAGATACCAAACATTTAGATTTGCAATTC 
vet-2 sgRNA_R CCGGTATCCTATGATCCAACCAAACATTTAGATTTGCAATTC 
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Preparation of HR donor vectors 
pie-1 donor plasmids (point mutations and gfp and flag-fusions): pie-1 genomic 
sequence (LGIII:12,425,767-12,428,049) was amplified using the primers C_PIE-
1 PF and C-PIE-1 PR and the resulting PCR product was inserted into the 
pCRtm-Blunt II-TOPO® vector (Invitrogen, cat. no. K2800-20). 
The K68A and K68R mutations were introduced by PCR sewing (or 
overlap extension PCR). The pie-1 plasmid described above was used as a 
template to generate overlapping PCR products with the corresponding site-
specific mutations. The overlapping PCR products were mixed together (1:1), 
diluted 50-fold with water, and used as a template in the PCR-sewing step with 
an external primer pair. The fused PCR products were gel purified and cloned 
into the pCRtm-Blunt II-TOPO® vector. 
For building gfp::pie-1 donor constructs, an NheI restriction site was 
inserted immediately after and in frame with the start codon of pie-1 by PCR 
sewing. A plasmid containing wild-type or mutant pie-1 sequence was used as a 
template to generate a left arm PCR product flanked by BsiWI and NheI 
restriction sites and a right arm PCR product flanked by NheI and NgoMIV 
restriction sites. The products were digested with NheI, purified using a PCR 
cleanup kit, and ligated together. The ligated products were cloned into the 
pCRtm-Blunt II-TOPO® vector, and plasmids containing the appropriately ligated 
fragments were identified. A BsiWI and NgoMIV fragment, containing the in 
frame NheI site immediately after the start codon, was released and ligated to 
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similarly digested pie-1 constructs. The GFP coding region amplified from 
pPD95.75 (Addgene) was inserted into the NheI site. 
For pie-1::gfp or pie-1::flag, a 1.6 kb fragment (LGIII 12,428,172-
12,429,798) was amplified from genomic DNA and inserted into the pCRtm-Blunt 
II-TOPO® vector (Invitrogen, cat. no. K2800-20). Overlap extension PCR was 
used to introduce an NheI site immediately before the stop codon in this fragment 
of pie-1. A 3×flag sequence 
(gattacaaagaccatgatggtgactataaggatcatgatattgactataaagacgatgacgataag) was 
inserted into the NheI site.  
Finally, we used PCR sewing to introduce silent mutations that disrupt the 
PAM site (NGG to NTG) in each HR donor. The above plasmids were used as 
templates to generate the initial PCR products for PCR sewing. The final 
products were cloned into the pCRtm-Blunt II-TOPO® vector. We used iProofTM 
high-fidelity DNA polymerase (Bio-Rad, cat. no. 172-5300) in all PCR reactions 
above. Primers are listed in Table 1.3. 
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Table 1.3 Summary of primer sequences for repair template and PCR screening 
 
Name Sequence 
C_PIE-1 PF ATAGCCCGATTTTGGAGGTG 
C_PIE-1 PR CCTCGAATTTTGGCAATTTTTC 
C_PIE-1 301L ATGGATTTCTCGCCGTTTTTTC 
C_PIE-1 318R GTTGTATCCACGTCGTCTCG 
C_PIE-1(K68A)_F GGAAAATGGCTTCGTCCAGCACGTGAAGCG 
C_PIE-1(K68A)_R CTTGAGCGCTTCACGTGCTGGACGAAGCC 
C_PIE-1(K68R)_F GGAAAATGGCTTCGTCCTAGGCGTGAAGCG 
C_PIE-1(K68R)_R CTTGAGCGCTTCACGCCTAGGACGAAGCC 
C_PIE-1 a MF GCTATGTCTTTTAGTTGCAGGCGCCTC 
C_PIE-1 a MR CAGATTGACGAGGCGCCTGCAACTAA 
SMO-1 PF CGATTTTTCGGCTCATTTCG 
SMO-1 PR CCTCGTCAAATCCGAAATCG 
SMO MF CACCCATCAATCCCTTTTC 
SMO MR GAAAAGGGATTGATGGGTG 
P1F GTTTTTGCCCCCAAATTC 
P1R TGATGCTTCGATGCTGAAGA 
P2F GGCGTCAAAAGACATATGTAAAAG 
P2R CGCAATGGATGATTTTTGTC 
P3F GCCGAGCTATGTCTTTTAG 
P3R CTCAAGATCACTCCATTGGC 
P4F GGCGGTGCGTTTGAAGTGT 
P4R GGAAATAATAGTTGGTGGTGGC 
P5F CCATATTTTGTTTTGTATATTTATC 
P5R GGCACAAGTTCATTCACAGG 
S1F GAAGTGCACTTCCGTGTAAAGTATGGAACC 
S1R CCGGCTGCTATTTCATTGAT 
mc.out.F1 GCTCAAGAAAGCCAATGGAG 
mc.out R1 TTCTGAACCAGTCGATGCAG 
mc.in F1 ATGGAGGGATCTGTCAATGG 
mc.in R1 TGGCAGTCGAGACACTTCAG 
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mCherry::vet-2 and flag::vet-2 donor construct: A 2411 bp DNA fragment of the 
vet-2 gene, including 1249 bp of sequence upstream and 1162 bp downstream of 
the vet-2 start codon (corresponding to the genomic sequence LGI:10,845,543-
10,847,953), was amplified from genomic DNA and inserted into pBluescript KS 
(+) vector (Addgene). An XmaI site was introduced by PCR immediately after the 
vet-2 start codon. The mCherry coding sequence amplified from pCFJ90 
(Addgene) or 3×flag sequence was inserted into the XmaI site.  
 
smo-1::flag donor plasmid: smo-1 genomic sequence (LGI: 1,340,243-1,341,558) 
was amplified from N2 genomic DNA and inserted into the pCRtm-Blunt II-TOPO® 
vector (Invitrogen, cat. no. K2800-20). Overlap extension PCR was used to 
introduce an NheI site immediately before the stop codon in this fragment of 
smo-1. The resulting PCR product was cloned into the pCRtm-Blunt II-TOPO® 
vector. A 3×flag fragment with NheI overhangs was generated by annealing two 
overlapping oligonucleotides and ligated into the smo-1 donor plasmid. We 
mutated the PAM site as described for the pie-1 donors above. 
 
gfp::pie-1 for MosSCI: A 3744 bp fragment (ScaI-NotI) containing the pie-1 
promoter was excised from pID3.01B (Addgene) and inserted into a modified 
MosSCI LGII vector (B1496) in which a NotI site was added to pCFJ151 
(Frokjaer-Jensen et al., 2008; Shirayama et al., 2012). A 2631 bp PCR fragment 
containing the pie-1 open reading frame (ORF) and 3’ UTR was then inserted 
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into the resulting plasmid to make a gfp::pie-1 plasmid for MosSCI. The plasmid 
was injected into the strain EG4322 at a concentration of 10 ng/ml by direct 
injection method to insert a single copy gfp::pie-1 transgene on chromosome II at 
position 8,420,159. 
 
BSD-fusion to pie-1: The nucleotide sequence of the Blasticidin S resistance 
gene (BSD) from Aspergillus terreus was codon optimized for C. elegans and an 
artificial intron (gtaagagattttttaaaaatttattttttacactgttttttctcag) was inserted into the 
middle of the BSD ORF: the entire gene was de novo synthesized by GenScript. 
The BSD fragment containing the BSD ORF (439 bp), rpl-28 promoter (568 bp) 
and rpl-28 3’utr (568 bp) was inserted into pBluescript KS (+) vector (Addgene). 
The complete sequence of BSD marker is available upon request. A 1077 bp 
fragment of pie-1 left homology was inserted into the XbaI site before the rpl-28 
promoter  and a 1017 bp fragment of pie-1 right homology was inserted into the 
SalI-ApaI site after the rpl-28 3’utr. Blasticidin S (AG scientific, cat. no. B-1247) 
was used to select animals transformed with the BSD gene. 
 
Preperation of heat shock-Cas9 plasmid 
The Mos1 transposase ORF in pJL44 (Addgene) was replaced with Cas9 from 
Peft3::Cas9 vector (Friedland et al., 2013) to generate hs::Cas9 (pWU34) 
construct. 
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Microinjection 
DNA mixtures were microinjected into the gonads of young adult worms.  
Plasmids for injection were prepared using a midiprep plasmid purification kit 
(Qiagen, cat. no. 12143). For Co-CRISPR, we injected 50 ng/µl each vectors 
(Cas9 vector, unc-22 sgRNA vector (Co-CRISPR), two untested-sgRNAs, and 
pRF4::rol-6(su1006)). Microinjection mixtures for HR contained 50 ng/ul each 
Cas9 vector, sgRNA vector, pRF4::rol-6(su1006), and HR donor vector. The final 
concentration of DNA in the injection mix did not exceed 200 ng/µl. For injection 
mixes with 5 different plasmids, 40 ng/µl of each plasmid was added. For HR 
experiments, we injected about 40 to 60 worms, and for disruptions about 20 to 
30 worms. After recovering from injection, each worm was placed onto an 
individual plate.  
 
Screening for indels using Co-CRISPR 
In order to validate untested sgRNAs we injected mixtures containing the unc-22 
sgRNA and up to several untested sgRNAs (as described above).  Three days 
after injection, F1 rollers and F1 twitchers were picked individually to plates and 
allowed to produce F2 progeny for 2 to 3 days. F1 twitchers and F1 rollers with 
twitching F2 progeny were then transferred to 20 µl lysis buffer for PCR, 
polyacrylamide gel electrophoresis (PAGE) (see below) and/or DNA sequencing 
analysis. Total time from injection to indel detection was about 6 to 7 days.  
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Screening for HR events 
Direct detection of GFP:  This procedure works for donor vectors that cannot 
drive GFP without first integrating into the genomic target site. For GFP::PIE-1 it 
was necessary to mount gravid F1 rollers three at a time under cover slips on 2% 
agarose pads for screening at 40X magnification using a Zeiss Axioplan2 
microscope. For bright GFP constructs, it should be possible to screen using a 
fluorescence dissecting scope. GFP-positive animals were recovered by carefully 
removing the cover slip and transferring to individual plates. After laying eggs for 
1 day they were individually lysed in 20 µl lysis buffer for PCR confirmation of the 
GFP insertion. GFP-positive F2 homozygotes were then identified and correct 
insertion of GFP was confirmed by DNA sequencing.  Total time from injection to 
recovery of heterozygotes was 3 to 4 days. 
 
PCR detection:  F1 rollers were picked individually to plates and allowed to lay 
eggs for 1 day. For the co-CRISPR assay, F1 rollers were allowed to produce F2 
progeny for 2 to 3 days so that F2 twitcher progeny could be identified. (Note: F1 
roller animals that segregate twitching progeny should be selected as these 
animals exhibit the highest HR frequency, while non-rolling F1 twitchers should 
be avoided [see Results and Discussion]).  F1 animals were then transferred into 
lysis buffer in indexed PCR tubes and were screened using primers outside the 
homology arms followed by restriction enzyme digestion to detect the insertion.  
In some experiments, 1 µl of the initial PCR reaction was used as a template for 
	 37	
a second PCR reaction with primers within the donor sequences. Though useful, 
this latter procedure gave several false positives in our hands. Total time from 
injection to recovery of heterozygotes was 4 days. For the Co-CRISPR strategy, 
3 more days were required to recover heterozygotes.   
 
Selection/Counter-selection method: Four days after injection, gravid F1 rolling 
adults were placed in groups of 10 to 15 animals per plate onto media containing 
ivermectin and blasticidin. After 3 to 4 more days, the plates were scored for 
viable, fertile progeny. Insertion of BSD at the target locus was then confirmed by 
PCR and DNA sequencing (as described above). The total time from injection to 
recovery of HR events was 7 to 10 days. Though slightly longer in duration this 
procedure required approximately ten times less labor as only the relatively rare 
viable populations were subject to PCR and DNA sequence analysis. Primers for 
screening HR events are listed in Table 1.3. 
 
Imaging 
Images were captured with an ORCA-ER digital camera (Hamamatsu) and 
AxioVision (Zeiss) software. 
 
Screening for small indels by PCR and PAGE 
We designed primers to amplify (~30 cycles) PCR products of 60-65 bp 
encompassing the CRISPR-Cas9 target site. PCR products were resolved on 
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15% polyacrylamide gels to distinguish dsDNA molecules that differ by as little as 
1 bp. We found that we could screen for indels even in HR experiments, but it 
required two PCR steps. In the first PCR reaction (~20 cycles), primers outside of 
the homology arms were used to avoid amplifying the donor sequence. In the 
second reaction (~15 cycles), 1 µl of the first PCR reaction was used as a 
template to generate the 60-65 bp PCR product encompassing the CRISPR-
Cas9 target site. TaKaRa Ex TaqTM (Takara, cat. no. RR001) was used for the 
PCR reactions above. Primer sequences are listed in Table 1.3. 
 
Immunoblotting 
One hundred adult worms were lysed in 80 µl of 1X sample buffer (25 µl of M9 
containing 100 worms, 25 µl of 2X lysis buffer, 20 µl of 4X NuPAGE® LDS 
Sample buffer (Invitrogen, cat. no. NP0008), and 10 µl of β-mercaptoethanol by 
boiling for 20 min, freezing, and boiling again for 10 min. The worm lysate 
proteins were separated on 4-12% NuPAGE® Tris-Acetate Mini Gels (Invitrogen, 
cat. no. NP0335BOX). Proteins were transferred to Immun-Blot® PVDF 
Membrane (Bio-Rad, cat. no.162-0177) at 100 V for 1 hr at 4°C. Mouse 
monoclonal anti-PIE-1 antibody (P4G5) (Mello et al., 1996) and rabbit polyclonal 
anti-PGL-1 antibody was used at 1:50 and 1:500, respectively. 
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Results  
Using a visible co-transformation marker enriches for genome-editing 
events 
While conducting CRISPR-Cas9 experiments to induce mutations in the pie-1 
gene, we used the dominant co-injection marker rol-6 to monitor injection quality. 
From 60 injected animals, we obtained 93 fertile F1 rollers.  Remarkably, we 
noted that several of these F1 rollers (5/93) produced 100% dead embryos 
exhibiting the distinctive pie-1 maternal-effect embryonic lethal phenotype (Mello 
et al., 1996) (Figure 1.6A). Genomic sequencing of these F1 adults identified 
lesions in the pie-1 gene consistent with Cas9-directed cleavage (Figure 1.6B). In 
some cases the maternal and paternal alleles exhibited distinct lesions, while in 
others, the same lesion was found in both alleles (Figure 1.6B). Since the DNA 
was delivered into the ovary of an adult, after the switch from sperm to oocyte 
development, the paternal allele must have been targeted in the F1 zygote soon 
after fertilization. The fact that both alleles exhibit identical lesions in some 
animals suggests that a chromosome previously cut and repaired by NHEJ was 
used as a donor molecule to copy the lesion into the homolog. 
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Figure 1.6 Efficient CRISPR-Cas9-mediated gene disruptions in transgenic animals 
(A) Schematic representation of screen for CRISPR-Cas9 genome editing events. The 
dominant transformation marker rol-6 was co-injected with Cas9, pie-1 a sgRNA, and 
donor plasmids. F1 rollers were screened for NHEJ-mediated indels by DNA 
sequencing. Among 93 F1 rollers, 22 indels were obtained. (B) Sequences of the wild-
type pie-1 target site (top) and CRISPR-Cas9-mediated indels among F1 animals: (i) 
pie-1 homozygotes carrying the same indel on both alleles; (ii) pie-1 homozygotes 
carrying a different indel on each allele; and (iii) pie-1 heterozygotes. Lower case 
indicates insertion, and dash indicates deletion. The PAM is marked in red, and target 
sequences are marked in blue. The number of deleted (-) or inserted (+) bases is 
indicated to the right of each indel. The numbers in parentheses in (iii) represent the 
number of animals with the indels shown. 
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If the activation of Cas9 in the germline is broadly or non-specifically 
mutagenic, then some injected animals would be expected to segregate novel 
mutants, including mutants with non-pie-1 dead-embryo phenotypes.  To look for 
evidence of off-target mutagenesis, we screened among the progeny of F1 
rollers for animals producing dead embryos, or other visible phenotypes.  A 
careful examination of F2 and F3 populations revealed 17 populations from 93 
F1 rollers that segregated numerous dead embryos (Figure 1.6A). However, 
examination of these dead embryos by Nomarski microscopy revealed the 
distinctive pie-1 mutant phenotype, and no other phenotypes.  Each of these 17 
strains segregated pie-1 homozygotes at the expected Mendelian frequency, 
indicating that the original F1 rollers were heterozygous for pie-1 loss-of-function 
mutations. Sequencing of these strains revealed indels in the region of the pie-1 
gene targeted by CRISPR-Cas9 (Figure 1.6B). In some cases, to avoid the delay 
and added cost of DNA sequencing, genomic DNA prepared from lysates of each 
candidate was amplified as ~60 bp PCR products that were then analyzed on a 
15% PAGE gel. This analysis easily detected lesions as small as 5 nt (Figure 
1.6B and Figure 1.7A). 
In addition to F1 rollers, we randomly selected F1 non-roller sibling 
progeny that were produced during the same time window as the F1 rollers. 
Among 100 non-roller siblings, we failed to find animals segregating dead 
embryos. Thus, using the dominant visible rol-6 marker to identify F1 transgenic 
animals (rollers) also identified animals in which Cas9 was active. It is important 
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to note, however, that very few of the animals with pie-1 mutations continued to 
exhibit the roller phenotype in subsequent generations, suggesting that the rol-6 
transgene expression was transient and present only in the F1 generation. 
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Figure 1.7 Detecting small indels on 15% polyacrylamide gels   
(A) The indicated primers (arrows) were used to amplify sequences immediately 
surrounding the CRISPR-Cas9 target site (red). The indels in this experiment were from 
an HR experiment, so an initial PCR was performed using primers outside of the 
homology arms of the donor template (Figure 1.10A). The initial PCR was used as a 
template to amplify the target site using the indicated primers. PCR products from F1 
heterozygotes (left) and F2 homozygotes (right) were separated on a non-denaturing 
15% polyacrylamide gel and stained with ethidium bromide. The asterisk indicates the 
PCR product amplified from residual donor plasmids in the single worm lysate (B) and 
(C) Test of two uncharacterized pie-1 sgRNAs using the Co-CRISPR strategy and PAGE 
analysis. The pie-1 sgRNA vectors were combined and co-injected with the unc-22 
sgRNA, Cas9, and rol-6 plasmids. The pie-1 sgRNA target sites (shown in red and blue) 
are separated by 61 bp. As this experiment did not include an HR donor, only a single 
round of PCR was performed with the indicated primers (arrows). We lysed 11 F1 
animals with the twitching phenotype (#3, #8, and #9-11) or that produced twitching 
progeny (#1-2 and #4-7). WT, wild-type N2 genomic DNA was used as a template. 
Asterisks indicate lanes in which small indels were detected. The filled triangles indicate 
lanes in which the primer pair could not detect the indels. 
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A co-CRISPR strategy to detect genome-editing events 
In practice we have found that about half of sgRNAs tested are not effective.  
Thus, while the rol-6 marker was clearly useful for finding animals with CRISPR-
Cas9-induced lesions, we nevertheless frequently had to screen through dozens 
or even hundreds of F1 rollers by PCR or sequencing only to conclude that 
CRISPR-Cas9 was not active in the injection. We therefore reasoned that co-
injecting a proven sgRNA (one that works well and results in an easily 
recognized visible phenotype) would allow us to more directly identify animals in 
which Cas9 is active.  We tested this strategy using an sgRNA targeting the 
muscle structural gene unc-22 (Benian et al., 1993; Moerman and Baillie, 1979).  
We chose this sgRNA both because unc-22 loss of function causes a distinctive 
recessive paralyzed twitching phenotype that is easy to score and also because 
this sgRNA works moderately well compared to other sgRNAs (Table 1.1). Thus, 
F1 and F2 unc-22 twitchers should arise from animals exposed to the greatest 
levels of Cas9 activity, and should therefore also have active Cas9 loaded with 
the co-injected sgRNAs.  
To test the co-CRISPR strategy, we co-injected the unc-22 sgRNA with 
two previously validated sgRNAs targeting avr-14 and avr-15 (Figure 1.8A), two 
genes whose wild-type activities redundantly confer sensitivity to the potent 
nematicide ivermectin (Dent et al., 2000). The rol-6 marker was also included in 
these injections to facilitate the identification of twitchers that arise in the F2 
among the progeny of F1 roller animals. We then measured, among 55 F1 
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rollers, the frequency of ivermectin resistant strains (20%, n=11) and twitcher 
strains (11%, n=6) (Figure 1.8A). Strikingly, selecting for the twitching phenotype 
dramatically enriched for animals exhibiting ivermectin resistance. For example, 
among 8 F1 animals that were either twitching themselves or produced twitcher 
progeny, 7 (88%) also produced progeny resistant to ivermectin (Figure 1.8A and 
1.8C). We confirmed co-CRISPR activity by sequencing the lesions in several of 
these strains (Figure 1.8B). 
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Figure 1.8 “unc-22” Co-CRISPR as a marker to indicate actively expressed Cas9 
(A) Schematic of Co-CRISPR strategy to identify functional sgRNAs targeting avr genes. 
sgRNAs targeting avr-14 and avr-15 were co-injected with a functional unc-22 sgRNA, 
the Cas9 expression vector and the rol-6 transformation marker. F1 rollers or twitchers 
were transferred to individual plates. The plates were allowed to starve, and then they 
were copied to plates containing 2 ng/ml ivermectin to identify CRISPR-Cas9-induced 
avr-14; avr-15 double mutants. (B) Indel sequences in avr-14; unc-22; avr-15 triple 
mutants. avr-15 isolate #15 carried different indels on each allele. Sequences labeled 
with a question mark could not be precisely determined. (C) Comparison of twitcher-
based indel frequency and roller-based indel frequency. 
B
WT
#2
WT
#2
WT
#2
avr-14, avr-15, unc-22 triple mutants
avr-14
GATTGGAGAGTTAGACCACGTGGAATGAAT 
GATTGGAGAGTTAGAC - - - - - GGAATGAAT +59(-5, +64)
GATTGGAGAGTTAG - - - - - - TGGAATGAAT -6
GATTGGAGAGTT - - - - - - - - - GGAATGAAT -9
avr-15
E   F   A   W   V   T   Y   I   A   N
D   W   R   V   R   P   R   G   M   N
GAGTTCGCCTGGGTGACTTATATTGCAAAC 
GAGTTCGCCTGGGTGACTTATATTGCAAAC +2
#14
#15
GAGTTCGCCT - - - - GACTTATATTGCAAAC -4            
 - - - - - - - - - - - - - - - - - - - - - - - - - - - -AC    
unc-22
L   N   P   L   P   N   T   Q   E   I
CTGAACCCGTTGCCGAATACACAGGAGATC
- - - - - - - - - - - - - - - - - - - - - - ctctatTC -24(-30, +6)   
CTGAACCCGTTGCCGAA - - - - CAGGAGATC +8(-4, +12)
CTGAACCCGTTGCCGAA - - - caAGGAGATC -3(-5, +2) 
#14
#15
#14
#15
tc
GAGTTCGCC - - - - - - - - - - - - - - - - - - - - -        ?
?
A
Gene Number
Injected
avr-14
avr-15
pie-1 b
pie-1 c
F1 rollers 
producing F2 
twitchers/Total 
F1 rollers 
F1 having both 
rolling and 
twitching 
phynotype
F1
twitchers
Roller-based 
indel frequency
20
30
6/55
2/31
0
1
2
8
11/55 (20%)
2/32 (6%)
1/32 (3%)
7/8 (88%)
6/11(55%)
4/11(36%)
C
eft-3::cas9
50 ng/+l
sgRNA avr-14
50 ng/+l
rol-6 marker
50 ng/+l
Microinjection
sgRNA avr-15
50 ng/+l
sgRNA unc-22
50 ng/+l
55 F1 rollers 2 F1 twichers
6 F2 twichers49 F2 non-twichers
6/49
Ivermectin 
Resistant
5 /6
Ivermectin
Resistant
2/2
Ivermectin
Resistant
Ivermectin Ivermectin
Ivermectin
11/55 7/8
Twitcher-based 
indel frequency
Figure 1.3. “unc-22” Co-CRISPR as a marker to indicate actively expressed Cas9. (A) Schematic of Co-CRISPR strate-
gy to identify functional sgRNAs targeting avr genes. sgRNAs targeting avr-14 and avr-15 were co-injected with a func-
tional unc-22 sgRNA, the Cas9 expression vector and the rol-6 transformation marker. F1 rollers or twitchers were trans-
ferred to individual plates. The plates were allowed to starve, and then they were copied to plates containing 2 ng/ml 
ivermectin to identify CRISPR-Cas9-induced avr-14; avr-15 double mutants. (B) Indel sequences in avr-14; unc-22; 
avr-15 triple mutants. avr-15 isolate #15 carried different indels on each allele. Sequences labeled with a question mark 
could not be precisely determined. (C) Comparison of twitcher-based indel frequency and roller-based indel frequency.
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  Similar results were obtained in several additional Co-CRISPR 
experiments (Figure 1.8C and data not shown). For example, we used this 
approach to test two uncharacterized sgRNAs targeting the 3’ end of pie-1 
(Figure 1.8C and Figure 1.7B). Among 11 twitcher lines identified in the F1 or F2, 
we identified 3 indels by PCR and PAGE for one of the two sgRNAs (Figure 
1.7B) and a single indel for the other sgRNA (Figure 1.7C). Sequence analysis 
confirmed these indels, which included a 6 nt deletion, a 24 nt insertion, and an 
11 nt deletion for one sgRNA and a 16 nt insertion for the other. However, the 
PAGE detection method clearly underestimated the frequency of indels. 
Sequence analysis identified three heterozygous deletion mutations of 42 nt, 43 
nt, and 603 nt that deleted primer binding sites and were thus too large to be 
detected by our PCR and PAGE analysis (Figure 1.7B). These unusually large 
deletions may reflect simultaneous cutting induced by the two adjacent sgRNAs 
whose targets are separated by 61 bp in this experiment (Figure 1.7B). In 
conclusion, these findings suggest that PAGE analysis of 10 to 20 Co-CRISPR 
lines should be sufficient to determine if an uncharacterized sgRNA is active.  It 
should be noted that since many F1 rollers analyzed were heterozygous for unc-
22 lesions, it was usually possible to find non-uncs with the desired indel using 
the unc-22 Co-CRISPR assay. However, if unc-22 is inconvenient for a particular 
experiment our findings suggest that alternative Co-CRISPR sgRNAs targeting, 
for example, genes that when mutated confer resistance to ivermectin or 
benomyl or other genes with visible mutant phenotypes may be substituted. 
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The observation that using nearby sgRNAs can induce deletions that 
remove the intervening sequence is consistent with previous findings where large 
deletions were produced in this way (Horii et al., 2013; Ran et al., 2013; Ren et 
al., 2013; Wang et al., 2013; Zhou et al., 2014). Thus the co-CRISPR strategy 
should facilitate the identification of deletions that remove the interval between 
two sgRNAs. However, further experimentation will be required to determine how 
large an interval can readily be eliminated in this way. For the purpose of 
validating sgRNAs our findings suggest that large deletions produced by testing 
multiple nearby sgRNAs simultaneously may confound the analysis of which 
sgRNAs are active.  On the other hand, pooling sgRNAs targeting a number of 
different genes that are distant from one another in the genome should, in 
principle, allow several sgRNAs to be validated in a single Co-CRISPR 
microinjection experiment.   
 
Identification of HR events without a co-selectable marker 
We next sought to use CRISPR-induced double-strand breaks to drive 
homologous recombination (HR).  Several types of editing are possible, ranging 
from changing a single amino acid to inserting a protein tag such as GFP, or 
even deleting the entire target gene.  In designing donor molecules to introduce 
point mutations or epitope fusions, we found it necessary to alter the sgRNA 
target sequence in the donor by mutating the protospacer adjacent motif (PAM) 
site, or by introducing mismatches within the seed region (Cong et al., 2013; 
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Jiang et al., 2013; Jinek et al., 2012; Sternberg et al., 2014).  In our experience, 
failure to take this step frequently results in HR events containing CRISPR-Cas9-
induced indels or a very low frequency of HR events: sometimes 0% (data not 
shown). 
Previous studies successfully used single-stranded oligonucleotide donor 
molecules (Zhao et al., 2014) or double-stranded plasmid donor molecules 
(Dickinson et al., 2013) to induce HR events in C. elegans.  However these 
studies relied on screening for a selectable phenotype introduced by the HR 
event.  Given the high frequencies of NHEJ events detected in the studies above, 
we wondered if CRISPR-Cas9-mediated HR events could be recovered directly 
without the need for selection. 
To test this idea, we decided to use CRISPR-Cas9-mediated HR to 
introduce the gfp coding sequence immediately downstream of the start codon in 
the endogenous pie-1 locus (Figure 1.9A). The donor plasmid in this experiment 
contained NheI restriction sites flanking the gfp coding sequence, 1 kb homology 
arms, and a silent mutation that disrupts the PAM sequence at the sgRNA target 
site (Figure 1.9A). We generated three different donor constructs–gfp::pie-1(WT), 
gfp::pie-1(K68A) and gfp::pie-1(K68R). Each donor molecule was co-injected 
with vectors to express the sgRNA, Cas9, and rol-6 marker. We then directly 
examined the resulting F1 rolling animals for GFP::PIE-1 expression in the 
germline and embryos using epifluorescence microscopy (Figure 1.9B, see 
materials and methods).  
	 51	
Using this approach, we obtained 9 independent lines out of 92 F1 rollers 
for gfp::pie-1(K68A), 1 out of 69 for gfp::pie-1(K68R), and 1 out of 72 for gfp::pie-
1(WT). Subsequent analyses revealed that each of these F1 animals was 
heterozygous for gfp::pie-1, and each strain incorporated both the gfp coding 
sequence and the PAM site mutation, as well as the linked K68A and K68R 
missense mutations. For unknown reasons, we found that one of the nine 
gfp::pie-1(K68A) lines could not be maintained.  
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Figure 1.9 HR-mediated knock-in to generate fusion genes at endogenous loci  
(A) Schematic of the Cas9/sgRNA target site and the donor plasmid for gfp::pie-1 knock-
ins. The donor plasmid contains the gfp coding sequence inserted immediately after the 
start codon of pie-1, 1 kb of homology flanking the CRISPR-Cas9 cleavage site, and a 
silent mutation in the PAM site. (B) Strategy to screen for gfp knock-in lines. We placed 
3 F1 rollers at a time on a 2% agar pad and screened for GFP expression using 
epifluorescence microscopy. GFP-expressing worms were individually recovered and 
allowed to make F2 progeny for one day before being lysed for PCR and DNA sequence 
analysis. We confirmed Mendelian inheritance of gfp knock-in alleles among F2 progeny. 
(C) GFP::PIE-1 expression in the germline of 2- to 4-cell embryos of gfp::pie-1 knock-in 
strains. (D) Immunoblot analysis showing PIE-1 expression levels in wild-type animals, 
MosSCI-mediated gfp::pie-1 knock-in animals, and CRISPR-Cas9-mediated gfp knock-in 
animals. A MosSCI strain of gfp::pie-1; pie-1(zu154) was obtained by crossing gfp::pie-1 
(LGII) with the pie-1(zu154) (LGIII) null mutant. (E) mCherry expression in late embryos 
of the mCherry::vet-2 knock-in strain. (F) Schematic of Cas9/sgRNA target site, PAM 
site, and donor plasmid for pie-1::flag knock-in. The PAM is located in the last exon of 
pie-1. The donor plasmid includes flag coding sequence immediately before the pie-1 
stop codon and ~800 bp homology arms flanking the target site. (G) PCR and restriction 
analysis of an HR event. PCR products were generated using the primers indicated in 
(F), and the products were digested with NheI. The pie-1::flag gene conversion 
introduces an NheI RFLP that is observed in F1 heterozygous and F2 homozygous pie-
1::flag animals. 
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The high rates of HR observed in the above study, suggested that it 
should also be possible to recover HR events by screening DNA isolated from F1 
rollers using PCR. To test this idea, we designed donor molecules to insert the 
pie-1 lysine 68 lesions described above with either no tag sequences or with 
sequences encoding the FLAG epitope immediately before the stop codon of the 
pie-1 gene (Figure 1.9F and Figure 1.10A). For these HR experiments, we used 
300 bp (no tag) and 800 bp (flag tag) flanking homology arms along with 
previously tested sgRNAs (Figure 1.9F, Figure 1.7B, and Figure 1.10A). We then 
used PCR to amplify the genomic DNA sequence from F1 rollers and restriction 
analysis to identify F1 heterozygotes carrying the desired insertion (Figure 1.9G, 
Figure 1.10B, and Figure 1.10C). These studies identified two K68A HR events 
among 93 F1 rollers (60 injected worms), and 3 flag HR events among 84 F1 
rollers (40 injected worms) (data not shown). A similar PCR-detection strategy 
was used to introduce mcherry into the gene vet-2.  In this experiment, mCherry 
expression was not visible in adult F1 rollers, but was easily detected among the 
F2 embryos produced by PCR-positive animals (Figure 1.9E). Taken together 
these findings show that CRISPR-Cas9-mediated HR occurs at a remarkably 
high frequency in C. elegans.  
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Figure 1.10 Site-specific mutagenesis of pie-1 by HR  
(A) Schematic of the Cas9/sgRNA target sites in pie-1 locus and donor plasmids. The 
K68A donor plasmid contains ~300 bp of homology flanking the 52 bp target region 
between the K68 codon and PAM site and introduces a PmlI restriction site (red box). 
The PAM site of each donor was disrupted by silent mutations so that it will not be 
targeted by CRISPR-Cas9. The blue bar indicates the PAM site, and the red bar 
indicates the position of K68. (B) PCR and restriction enzyme analysis of wild-type 
control worms and F1 rollers from K68A CRISPR-Cas9-mediated HR experiments. PCR 
primers outside of the donor homology arms (P1F and P1R for K68A) are indicated in 
(A). Restriction analysis following PCR shows the RFLP in pie-1(K68A)/+. The wild-type 
product is indicated by the filled triangle. (C) DNA sequence analyses to confirm the 
desired point mutations. Note that the PCR products for sequencing were amplified 
using the primers outside of donor plasmid, as indicated in (A). 
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We compared the expression and localization of GFP::PIE-1 protein in our 
newly generated gfp::pie-1 knock-in strains to strains in which gfp::pie-1 was 
inserted at a heterologous site in the genome by MosSCI (Frokjaer-Jensen et al., 
2008; Shirayama et al., 2012). The knock-in strains showed the expected 
localization of PIE-1 in 2- to 4-cell embryos (Figure 1.9C). Strikingly, immunoblot 
analysis using the PIE-1 monoclonal antibody (P4G5) revealed that GFP::PIE-1 
protein was expressed at a much higher level in the CRISPR-Cas9-induced 
knock-in strains, similar to the expression level of endogenous PIE-1 protein 
(Figure 1.9D). These results are consistent with a previous study (Dickinson et 
al., 2013) and indicate, perhaps not surprisingly, that insertion of GFP into the 
endogenous locus can achieve near optimal expression levels of the tagged 
protein.   
 
Co-CRISPR for identifying HR events 
Most of the HR work described above was done before we realized the utility of 
co-CRISPR markers for validating sgRNAs. To determine if the co-CRISPR 
strategy could facilitate recovery of HR events, we co-injected unc-22 sgRNAs 
along with CRISPR HR injection mixes targeting vet-2, pie-1 and smo-1 genes 
(Figure 1.11). The findings from these studies suggest that using a co-CRISPR 
marker can increase the frequency of HR events in the range of approximately 2- 
to 4-fold over those observed by first selecting F1 roller animals (Table 1.4).  
	 57	
 
 
Figure 1.11 HR donor plasmids used in Co-CRISPR experiments  
(A) Schematic of the flag::vet-2 donor plasmid. The flag coding sequence was inserted 
immediately after the vet-2 start codon and flanked by ~1200 bp homology arms. (B) 
Schematic of the pie-1::gfp donor plasmid. (C) Schematic of the smo-1::flag donor 
plasmid. The donor plasmid includes flag coding sequence immediately before the smo-
1 stop codon and asymmetrical homology arms (~800 bp and ~500 bp) flanking the 
target site, and the Cas9/sgRNA target sequence is located in the 3’UTR of smo-1. The 
PAM sites mutated in each donor indicate the locations of the Cas9/sgRNA target sites. 
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Interestingly, however, these studies required a modification to the Co-CRISPR 
screening strategy.  For testing sgRNAs using Co-CRISPR, we found that F1 and 
F2 twitchers were equally likely to exhibit co-induction of indels with the second 
sgRNA. However, our data suggest that HR events were not enriched and might 
be depleted among non-rolling, F1 twitcher animals.  One possible explanation 
for this surprising finding is that Cas9-sgRNA complexes may assemble in the 
germline cytoplasm and then segregate into maturing oocytes independently of 
the co-injected DNA (including both the roller DNA and of course the donor DNA 
plasmids). Zygotes inheriting programmed Cas9 could undergo Non-homologous 
end joining (NHEJ) but HR-directed repair would not be possible without the 
donor vector.  Consistent with this reasoning, we found that in most cases HR 
events were only enriched among F1 animals that were both rolling, and thus 
had inherited the injected DNA, and also segregated twitching progeny, 
indicating that Cas9 was active (Table 1.4). For example among 145 F1 rollers, 
we found 7 animals heterozygous for a 3’ insertion of gfp into the pie-1 locus. 
Among the F1 twitchers that were non-rolling, zero were GFP-positive, while 
among the 4 F1 rollers that segregated twitching progeny, two (50%) were GFP 
positive.  One convenient aspect of searching for HR events among F1 rollers 
heterozygous for unc-22 twitchers was that the unlinked twitcher phenotype 
could easily be segregated away in subsequent generations. These findings 
suggest that Co-CRISPR screening can enhance the detection of HR events. 
Indeed, we always found at least one HR event among the F1 rollers with 
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twitcher progeny (3/29, 2/4 and 1/12).  However, in most cases additional HR 
events were also recovered by scoring all the F1 rollers (Table 1.4).   
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Table 1.4 Co-CRISPR strategy for HR events 
 
HR 
donor/ 
Targeted 
gene 
Number 
Injected 
F1 rollers 
producing 
F2 
twitchers/ 
Total F1 
rollers 
F1 having 
both rolling 
and 
twitching 
phenotype 
F1 
twitchers 
F1 
Twitcher-
based HR 
frequency 
Roller- 
based HR 
frequency 
Roller 
producing 
F2 
twitchers-
based HR 
frequency 
 
flag::vet-
2/ 
vet-2 
 
40 29/65 0 62 2/62 (3%) 
4/65 
(6%) 
3/29 
(10%) 
 
pie-
1::gfp/ 
pie-1 
 
40 4/145 0 7 0/7 (0%) 
7/145 
(5%) 
2/4 
(50%) 
 
smo::flag
/ 
smo-1 
 
40 12/55 10 22 1/22 (5%) 
1/55 
(2%) 
1/12 
(8%) 
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A selection/counter-selection strategy for recovering HR events 
The above findings demonstrate that selections are not necessary for identifying 
and recovering HR events using the CRISPR-Cas9 system.  However, for some 
experiments a dominant selection could save considerable time and expense, 
especially where insertion of heterologous DNA is likely to be tolerated, for 
example when generating a null allele of a gene or when one wishes to precisely 
delete non-coding genes or regulatory elements. The inserted marker also has 
the potential benefit of providing a selection for maintaining strains that may not 
be homozygous viable. Previous studies have described several selection 
strategies, including unc-119, NeomycinR, PuromycinR and HygromycinR 
(Frokjaer-Jensen et al., 2012; Frokjaer-Jensen et al., 2008; Giordano-Santini et 
al., 2010; Radman et al., 2013; Semple et al., 2010).  In order to test a selection 
counter-selection scheme for CRISPR-induced HR, we decided to employ a new 
worm antibiotic-resistance marker expressing the bacterial BSD as selectable 
marker, and the avr-15 gene as a counter-selectable marker. We have previously 
shown that introducing an avr-15(+) plasmid into extrachromosomal arrays and 
balancer chromosomes can be used to facilitate their counter selection 
(Duchaine et al., 2006; Shirayama et al., 2012). The avr-15(+) vector expresses a 
gene that confers sensitivity to the potent nematicide drug, ivermectin. This 
counter-selection can be used to remove BSD(+) extrachromosomal transgenes, 
thus facilitating the recovery of animals bearing an HR-induced insertion of the 
selectable marker. This counter-selection approach requires a starting strain 
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resistant to ivermectin, which is conferred by lesions in both the avr-14 and avr-
15 genes.  Ivermectin resistant double mutant strains are essentially wild-type in 
appearance, and as noted above, new strains can readily be rendered ivermectin 
resistant by simply co-injecting sgRNAs targeting avr-14 and avr-15 (Figure 1.8).  
To test this selection/counter-selection strategy we first designed a donor 
plasmid containing the BSD gene flanked with 1 kb pie-1 homology arms (Figure 
1.12A).  We injected 58 ivermectin-resistant animals with a mix containing this 
donor plasmid along with a validated pie-1 sgRNA vector, the Peft-3::Cas9 
vector, the rol-6 vector and the avr-15(+) vector.  Gravid F1 rollers were then 
placed approximately 11 per plate directly onto plates containing both blasticidin 
and ivermectin (Figure 1.12B, see materials and methods). After 3 to 4 days we 
found that two of fourteen plates produced blasticidin-resistant, fertile animals 
(Figure 1.12B). In a second experiment, we injected the same injection mixture 
into 40 animals and obtained 103 F1 rollers, from which we identified four 
blasticidin-resistant strains. 
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Figure 1.12 A blasticidin-resistance marker to select pie-1 knockout mutants 
(A) Schematic of the Cas9/sgRNA target site and an HR donor plasmid in which a 
heterologous blasticidin-resistance (BSD) gene replaces a region of pie-1 and is flanked 
by 1 kb homology arms. The BSD gene is under the control of the rpl-28 promoter (568 
bps) and 3’ utr (568 bps). (B) Schematic representation of the blasticidin selection 
strategy to precisely delete the pie-1 gene. pie-1 a sgRNA was co-injected with the Cas9 
expression vector, the rol-6 transformation marker, the pie-1∆::BSD donor construct, and 
the pCCM416::Pmyo-2::avr-15(+) counter-selection vector. The indicated number of F1 
rollers was transferred to the plates containing 2 ng/ml ivermectin to select against the 
extra-chromosomal array, and 100 µg/ml blasticidin to identify BSD knock-in lines. We 
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identified two plates with resistant, fertile adults among 14 plates, 3 to 4 days after 
transferring animals. 
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Discussion 
Optimizing sgRNA and donor molecule selection 
There is much work still to do in order to optimize CRISPR methodology for C. 
elegans.  For example, it remains unclear at this point why upwards of half of the 
sgRNAs tested fail to induce events. The sgRNAs that we have tested and the 
activities observed are summarized in Table 1.1, and all of the active sgRNA 
vectors will be made available through (Addgene). Another area requiring more 
study is how best to optimize HR donors.  All of the HR donor molecules used in 
the experiments described here were circular plasmids with at least 300 bp 
homology arms (Figure 1.10A). For GFP insertion we used either 800 bp or 1 kb 
homology arms, and observed roughly equal frequencies of HR in both cases 
(Figure 1.9A and Figure 1.11B). Future studies should explore shorter homology 
arms and other types of donor molecules including linear dsDNA donor 
molecules produced, for example, by PCR, as well as chemically synthesized 
ssDNA. It will also be important to explore the optimal distance between the cut 
site and the homology arm. Increasing this distance requires longer gene-
conversion tracts, and in other organisms is correlated with reduced frequency of 
the desired homologous event (Paques and Haber, 1999). Our findings suggest 
that gene-conversion tracts of approximately 250 bp are common in C. elegans.  
Optimizing HR conditions for each type of donor molecule will likely require 
extensive experimentation in order to generate statistically significant findings on 
relative efficiencies. Although there is still much work to do, the efficiencies 
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reported here are already remarkably high. For example, indels were frequently 
identified in greater than 10% of F1 rollers, and the ratio of HR events to the total 
number of CRISPR-Cas9-induced-repair events was consistently in the range of 
10% over the course of all of our experiments where both HR and indels were 
monitored. 
 
Conclusions 
Our findings provide a versatile framework for using CRISPR-Cas9 genome 
editing in C. elegans, and the Co-CRISPR strategy we employ is likely to be of 
value for CRISPR-Cas9 studies in other organisms. The tools described here, 
however, are likely to be just the beginning of what will be possible in the near 
future.  For example, the use of catalytically inactive Cas9 fusion proteins to 
tether regulators to DNA targets has not been described yet in C. elegans, but it 
is already finding many exciting applications in other systems (Cheng et al., 
2013; Kearns et al., 2014; Larson et al., 2013; Mali et al., 2013a; Qi et al., 
2013).  CRISPR-Cas9 technology should also dramatically facilitate the use of 
other nematode models, including species distantly related to Caenorhaditis 
elegans and perhaps parasitic nematodes.  The ability to efficiently engineer 
genomes will only enhance the utility of model organisms where gene variants 
can now be generated and analyzed rapidly and cost-effectively, facilitating the 
production of new animals models for human disease-associated 
alleles.  Moreover, CRISPR-Cas9-engineered strains with special alleles of 
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important genes can be used as starting strains in forward genetic screens, 
including suppressor and enhancer screens, which are extremely powerful in C. 
elegans.  It is now easier than ever for researchers to use C. elegans to explore 
the function of conserved genes of interest.  Indeed, the CRISPR-Cas9 
technology lowers the barrier to move from one system to another, effectively 
making all organisms one, when exploring conserved cellular mechanisms. 
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CHAPTER II: PIE-1, SUMOYLATION, AND EPIGENETIC REGULATION OF 
GERMLINE SPECIFICATION IN C. ELEGANS  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 69	
Introduction 
During embryogenesis, the most fundamental event in many organisms is the 
differentiation of germline cells and specialized somatic cells (Ikenishi, 1998).  In 
C. elegans, the separation of the germline from the soma occurs during the first 
four embryo cleavages (Sulston et al., 1983). PIE-1 is a tandem CCCH-type zinc-
finger protein essential for the germline fate (Mello et al., 1996). In the germline 
blastomere, PIE-1 inhibits embryonic transcription in the nucleus (Mello et al., 
1992; Seydoux et al., 1996) and promotes maternal gene expression in the 
cytoplasm (Tenenhaus et al., 2001). PIE-1 interacts with the NuRD complex, 
which is required to repress the germline fate in somatic cells (Unhavaithaya et 
al., 2002), suggesting that PIE-1 and NuRD have antagonistic activities. 
Consistent with this idea, somatic expression of PIE-1 mimics MEP-1 loss of 
function and results in ectopic expression of germline genes and stem cell fates 
in the soma (Unhavaithaya et al., 2002). However, the molecular mechanisms by 
which PIE-1 functions in germline blastomeres remain to be determined.  
Here, we investigated the functional consequence of the interaction 
between PIE-1 and SUMOylation, a post-translational modification with important 
biological functions. We aimed to address whether the SUMOylation of PIE-1 and 
associated chromatin-remodeling factors is required for transcriptional repression 
and epigenetic regulation in the C. elegans germline. Understanding the 
epigenetic mechanisms involved in germline specification will provide information 
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about the molecular mechanisms that control the maintenance and differentiation 
of germline stem cells. 
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Materials and Methods 
Yeast two-hybrid analysis 
The yeast two-hybrid screen was performed by Hybrigenics services (Paris, 
France, http://www/hybrigenics-services.com). The coding sequence for amino 
acids 2–335 of C. elegans pie-1 (NM_001268237.1) was amplified by PCR from 
N2 cDNA and cloned into pB66 via C-terminal fusion with the Gal4 DNA-binding 
domain (Gal-4-PIE-1). The construct was checked by sequencing and used as a 
bait to screen a random-primed C. elegans Mixed Stages cDNA library 
constructed into pP6. 5 million clones (5-fold the complexity of the library). The 
library was screened using a mating approach with YHGX13 (Y187 ade2-
101::loxp-kanMX-loxP, matα) and CG1945 (mata) yeast strains as previously 
described (Fromont-Racine et al., 1997). 153 His+ colonies were selected on a 
medium lacking tryptophan, leucine, and histidine, and supplemented with 0.5 
mM 3-aminotriazole to prevent bait autoactivation. The prey fragments of the 
positive clones were amplified by PCR and sequenced at their 5’ and 3’ 
junctions. The resulting sequences were used to identify the corresponding 
interacting proteins in the GenBank database (NCBI) using a fully automated 
procedure. A confidence score (predicted biological score [PBS]) was attributed 
to each interaction as previously described (Formstecher et al., 2005). 
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C. elegans strains and genetics 
The strains and alleles used in this study were N2 Bristol (wild-type), pie-
1(zu154) unc-25 (e156)/qC1, rde-3(ne3370), and lines newly generated using 
CRISPR/Cas9-mediated genome editing as described in Table 2.1. Worms were, 
unless otherwise stated, maintained at 20°C on NGM plates seeded with OP50 
Escherichia coli, and genetic analyses were performed essentially as described 
(Brenner, 1974). 
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Table 2.1 Summary of experimental models: CRISPR strains 
ubc-9(G56R) ubc-9(ne4446[UBC-9(G56R)]) This study 
3xflag::smo-1 smo-1(ne4309[3xFLAG::SMO-1]) This study 
his10::smo-1 smo-1(ne4346[10XHIS::SMO-1]) This study 
pie-1(K68R) pie-1(ne4303[PIE-1(K68R)]) (Kim et al., 2014) 
pie-1(K68R)::3xflag pie-1(ne4304[PIE-1(K68R)::3xFLAG) This study 
pie-1::3xflag pie-1(ne4302[PIE-1::3xFLAG]) (Kim et al., 2014) 
pie-1::gfp pie-1(ne4301[PIE-1::GFP]) (Kim et al., 2014) 
pie-1(K68R)::gfp pie-1(ne4377[PIE-1(K68R)::GFP] This study 
mep-1::gfp::tev::3xflag 
mep-1(ne4380[MEP-
1::GFP::TEV::3xFLAG]) 
This study 
pgl-1::mCherry pgl-1(ne4394[PGL-1::mCherry]) This study 
pie-1(DAQMEQT)::3xflag 
pie-1(ne4389[PIE-
1(DAQMEQT)::3xFLAG]) 
This study 
pie-1(DAQMEQT)::gfp pie-1(ne4378[PIE-1(DAQMEQT)::GFP]) This study 
cdk-12-as cdk-12([CDK-12(F383G)]) 
Gift from Hermand 
Damien, University  of 
Namur, Belgium 
gcna-1(Δ2bp) gcna-1(ne4334[GCNA-1(Δ2bp)]) (Carmell et al., 2016) 
gcna-1(Δ1748bp) gcna-1(ne4356[GCNA-1(Δ1748bp)] (Carmell et al., 2016) 
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CRISPR/Cas9 genome editing 
The Co-CRISPR strategy (Kim et al., 2014) using unc-22 sgRNA as a co-
CRISPR marker was used to enrich HR events for tagging a gene of interest with 
the non-visualizing epitope (10xhis and 3xflag) or introduction of a point mutation 
(G56R). To screen for insertions of 10xhis and 3xflag, we used two-round PCR: 
the First PCR was performed with primers (F: cctcaaaaaccaagcgaaaacc R: 
ccggctgctatttcattgat), and 1 µl of the 1st PCR product was used as a template for 
the 2nd PCR with primers (F:gagactcccgctataaacga R:ctcaagcaggcgacaacgcc). 
To detect 10xhis knock-ins, the final products were run either on 2% 
Tris/borate/EDTA (TBE) gel or 10% PAGE gel. The ubc-9(G56R) mutation 
introduced an HaeIII restriction fragment length polymorphisms (RFLP) that was 
used to screen for G56R conversion in PCR products (F: cattacatggcaagtcggg, 
R: cgttgccgcatacagaaatag). For visualization of either GFP or mCherry tag, F1 
rollers were mounted under coverslips on 2% agarose pads to directly screen for 
GFP or mCherry expressing animals as described previously (Kim et al., 2014). 
 
sgRNA construct 
Previously generated pie-1 sgRNA plasmid (Kim et al., 2014) was used for pie-1 
(DAQMEQT)::3xflag. ubc-9 sgRNA (ggctcgaacttgcactttgg), smo-1 sgRNA 
(gagactcccgctataaacga), pgl-1 sgRNA (cgtggacgtggtggttacgg), and mep-1 
sgRNA (gcgcaaaagaaggaagacgg) were constructed by ligating annealed sgRNA 
oligonucleotides to Bsal-cut pRB1017 (Arribere et al., 2014).  
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Donor template 
Unless otherwise stated, a silent mutation to disrupt the PAM site in each HR 
donor was introduced by PCR sewing. 
 
ubc-9(G56R): For the ubc-9(G56R) donor construct, a ubc-9 fragment was 
amplified with primers (F: cattacatggcaagtcggg, R: gacgactaccacgaagcaagc) and 
this fragment was cloned into the Blunt II-TOPO vector (Invitrogen, K2800-20). 
To introduce the point mutation (G56R) and mutate the seeding region, overlap 
extension PCR was used (Figure 2.1C). 
 
his10::smo-1 and 3xflag::smo-1: Using PCR sewing, either a 10xhis fragment 
(caccatcaccatcaccatcaccaccatcac) or NheI site was introduced immediately after 
the start codon in the previously generated smo-1 fragment (Kim et al., 2014). 
The resulting PCR product was cloned into the Blunt II-TOPO vector. A 3xflag 
fragment with NheI overhangs was generated by annealing two oligonucleotides 
and ligated into the smo-1 donor plasmid by the NheI site. Tagging with either 
10xhis or 3xflag on the N-terminus of smo-1 disrupted the PAM site.  
 
pgl-1::mCherry: The pgl-1 genomic sequence was amplified from N2 genomic 
DNA with primers (F:	gtagctctgccaccggtatc, R:	gcgggaagaccatcgaaaaatag) and 
inserted into pCR-Blunt II-TOPO vector. Overlap extension PCR was used to 
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introduce a NheI site immediately before the stop codon in this fragment of pgl-1. 
The mCherry-coding sequence amplified from pCFJ90 (Addgene) was inserted 
into the NheI site. 
 
pie-1(DAQMEQT)::3xflag and pie-1(DAQMEQT)::gfp : To introduce the 
DAQMEQT mutations into either the pie-1::flag  or pie-1::gfp donor plasmid 
previously built in pCR-Blunt II TOPO (Kim et al., 2014), PCR sewing was 
performed with primers: 1st left arm product (F: gaaaacggcttctcagacca R: 
gtagtatgtctgctccatctgcgcatccattggctggctattc), 1st right arm product (F: 
gccagccaatggatgcgcagatggagcagacatactactatc, R: tacaaagtccgcaactgtgc), and 
2nd sewing PCR product (F: gaaaacggcttctcagacca R: tacaaagtccgcaactgtgc). 
The 2nd PCR products were gel-purified and cloned into the pCR-Blunt II Topo 
vector. 
 
mep-1::gfp::tev::3xflag: For the mep-1::gfp::tev::3xflag donor construct, a mep-1 
fragment was amplified with primers (F1:gaaattcgctggcagtttct R1: 
ctgcaacttcgatcaatcga) from N2 genomic DNA and inserted into the pCR-Blunt II-
TOPO vector. Overlap extension PCR was used to introduce an NheI site 
immediately before the stop codon in this mep-1 fragment. The NheI site was 
used to insert the gfp::tev::3xflag coding sequence.  
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RNAi 
RNAi was performed by feeding worms E. coli strain HT115 (DE3) transformed 
with the control vector or a gene-targeting construct from the C. elegans RNAi 
Collection (Kamath and Ahringer, 2003). L4 larval stage animals were placed on 
RNAi plates (NGM plates containing 1mM isopropyl β-d-thiogalactoside (IPTG) 
and 100 µg/ml ampicillin seeded with dsRNA-containing bacteria) and allowed to 
develop into adults. After 24h, adult animals were transferred to fresh RNAi 
plates and allowed to lay eggs over night. On the following day, the unhatched 
eggs were analyzed 12 h later after adults were removed from the test plates. 
 
Immunofluorescence 
Gonads were dissected and embryos were prepared by bleaching synchronous 
adult animals. Samples were placed on glass slides coated with 0.1% (w/v) Poly-
L-lysine solution (Sigma-Aldrich, P8920) and fixed with 4% paraformaldehyde in 
phosphate-buffered saline (PBS) for 20min, freeze-cracking on dry ice, and –
20°C cold methanol for 5min. After fixation, slides containing samples were 
washed three times with PBST (PBS containing 0.1% Triton X-100), blocked with 
0.1% bovine serum albumin (BSA) in PBST for 30 min, and then incubated with 
primary antibodies overnight at 4°C or for 1h at room temperature. After three 
washes with PBST, secondary antibodies were applied for 1h at room 
temperature. Sample slides were washed three times with PBS and mounted 
with 10 µl of Vectashield with DAPI (VWR, 101098-44). The primary antibodies 
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(1:100) used were: anti-acetyl-histone H4 (Thermo Fisher Scientific, 06855MI), 
anti-acetyl-histone H3Lys9 (Millipore Sigma, 07-352), anti-trimethyl-histone 
H3Lys9 (Millipore Sigma, 051250), and anti-NPP-9 (Novus Biologicals, 
48610002). The secondary antibodies (1:1000) used were: goat anti-rabbit 
IgG(H+L) Alexa Fluor 647(Thermo Fisher Scientific, A32733) and goat anti-
mouse IgG(H+L) Alexa Fluor 488 (Thermo Fisher Scientific, A11001). 
  
Microscopy 
For live imaging, worms and embryos were mounted in M9 on a 2% agarose pad 
with or without 1mM levamisole (Sigma-Aldrich, 16595-80-5). Epi-fluorescence 
and differential interference contrast (DIC) microscopy were performed using an 
Axio Imager M2 Microscope (Zeiss). Images were captured with an ORCA-ER 
digital camera (Hamamatsu) and processed using Axiovision software (Zeiss). 
Confocal images were acquired using a Zeiss Axiover 200M microscope 
equipped with a Yokogawa CSU21 spinning disk confocal scan head and custom 
laser launch and relay optics (Solamere Technology Group). Stacks of images 
were taken and analyzed using ImageJ. 
 
Immunoprecipitation 
Either synchronous adult worms (~200,000 animals) or early embryos (bleached 
from 10×100,000 adult animals) were collected and washed three times with M9 
buffer before being homogenized in lysis buffer [20mM HEPES pH 7.5, 125mM 
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Na3C6H5O7 (sodium citrate), 0.1%(v/v) Tween 20, 0.5%(v/v) Triton X-100, 2mM 
MgCl2, 1mM DTT, and a Mini Protease Inhibitor Cocktail Tablet (Roche)] using a 
FastPrep-24 benchtop homogenizer (MP Biomedicals). Worm or embryo lysates 
were centrifuged twice at 14,000×g for 30 min at 4°C, and supernatants were 
incubated with GFP-binding protein (GBP) beads for 1.5 h at 4°C on a rotating 
shaker. The beads were washed three times with immunoprecipitation (IP) buffer 
containing protease inhibitor for 5 min each wash and then washed twice with 
high-salt wash buffer (50mM HEPES pH 7.5, 500mM KCl, 0.05% NP40, 0.5mM 
DTT, and protease inhibitor). Immune complexes were eluted with elution buffer 
(50mM Tris-Cl pH 8.0, 1xSDS) for 10 min at 70°C.  
 
In vivo SUMO purification  
Synchronous adult worms (~200,000) or 500 µl of packed embryos (bleached 
from (~1,000,000 synchronous adult worms) were homogenized in lysis buffer at 
pH 8.0 (6M guanidine-HCl, 100mM Na2HPO4/NaH2PO4 pH 8.0, and 10mM Tris-
HCl pH8.0) using a FastPrep-24 benchtop homogenizer (MP Biomedicals). 
Lysates were cleared by centrifugation at 14,000×g for 30 min at 4°C and 
equalized using quick start Bradford 1x dye reagent (BioRad, 5000205). Ni-NTA 
resin was washed three times with lysis buffer containing 20mM imidazole pH 8.0 
and 5mM β-mercaptoethanol while samples were prepared. To equalized 
samples, we added imidazole pH 8.0 to 20mM and β-mercaptoethanol to 5mM, 
and then the samples were incubated with 100 µl of pre-cleared 50% slurry of Ni-
	 80	
NTA resin (Qiagen, 30210) for 2–3 h at room temperature on a rotating shaker. 
Ni-NTA resin was washed in 1-ml aliquots of the following series of buffers: 
Buffer 1 pH 8.0 (6M guanidine-HCl, 100mM Na2HPO4/NaH2PO4 pH 8.0, 10mM 
Tris-HCl pH 8.0, 10mM imidazole pH 8.0, 5mM β-mercaptoethanol, and 0.1% 
Triton X-100), Buffer 2 pH 8.0 (8M urea, 100mM Na2HPO4/NaH2PO4 pH 8.0, 
10mM Tris-HCl pH 8.0, 10mM imidazole pH 8.0, 5mM β-mercaptoethanol, and 
0.1% Triton X-100), Buffer 3 pH 7.0 (8M urea, 100mM Na2HPO4/NaH2PO4 pH 
7.0, 10mM Tris-HCl pH 7.0, 10mM imidazole pH 7.0, 5mM β-mercaptoethanol, 
and 0.1% Triton X-100), Buffer 4 pH 6.3 (8M urea, 100mM Na2HPO4/NaH2PO4 
pH6.3, 10mM Tris-HCl pH 6.3, 10mM imidazole pH 6.3, 5mM β-mercaptoethanol, 
and 0.1% Triton X-100), Buffer 5 pH 6.3 (8M urea, 100mM Na2HPO4/NaH2PO4 
pH 6.3, 10mM Tris-HCl pH 6.3, and 5mM β-mercaptoethanol). To purify the 
polyhistidine-tagged proteins under denaturing conditions, 8M urea was added to 
all wash buffers. Triton-X-100, the non-ionic detergent was used to reduce 
nonspecific hydrophobic interactions. Imidazole (10mM) was used to increase 
the stringency of the wash by reducing nonspecific protein binding to the resin. 
The use of wash buffers with gradually decreasing pH (pH8 to pH6.3) also 
reduced nonspecific binding of proteins by protonating the neutral histidine and 
thereby removing the weakly bound proteins that may contain tandem repeats of 
the histidine. The SUMOylated proteins were eluted with elution buffer pH 7.0 
(7M urea, 100mM Na2HPO4/NaH2PO4 pH 7.0, 10mM Tris-HCl pH 7.0, and 
500mM imidazole pH 7.0) For western blotting, input samples containing 
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guanidine-HCl were diluted with H2O (1:6) and then purified by trichloroacetic 
acid (TCA) precipitation: an equal volume of 10% TCA was added to diluted 
samples, which were then incubated on ice for 20 min and centrifuged for 20 min 
at 4°C; the obtained pellet was washed with 100 µl of ice-cold ethanol and then 
resuspended in Tris-HCl buffer pH 8.0. 
 
Western blot analysis 
NuPage LDS sample buffer (4x) (Thermo Fisher Scientific, NP0008) was added 
to samples, which were then loaded on precast NuPAGE Novex 4-12% Bis-Tris 
protein gel (Thermo Fisher Scientific) and transferred onto a polyvinylidene 
difluoride (PVDF) membrane (Bio-Rad) using Mini Trans-Blot cells (Bio-Rad) at 
80 V for 2.2 h at 4°C. Membranes were blocked with 5% skim milk and probed 
with primary antibodies: anti-FLAG (1:1000) (Sigma-Aldrich, F1804), anti-GFP 
(1:500) (Roche, 11814460001), anti-HDA-1 (1:1000) (Novus Biologicals, 
38660002), anti-Let-418 (1:1000) (Novus Biologicals, 48960002), anti-SMO-1 
(1:1000) (purified from Hybridoma cell cultures), and anti-PIE-1(P4G5) (1:100). 
Antibody binding was detected with secondary antibodies (1:2500): goat anti-
mouse (Abcam, ab6789) and goat anti-rabbit (Thermo Fisher Scientific, 656120). 
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Results 
Interaction of PIE-1 with SMO-1, UBC-9, and GEI-17 
To explore the molecular mechanisms by which PIE-1 functions in transcriptional 
regulation for germline specification, we sought to identify putative interacting 
partners of PIE-1 by yeast two-hybrid screening. In this screen, we used the full-
length pie-1 cDNA as bait and a mixed-stage C. elegans cDNA library as prey. 
Interestingly, SMO-1 (SUMO) and two enzymes involved in the SUMOylation 
pathway, UBC-9 (E2 SUMO enzyme) and GEI-17 (E3 SUMO ligase), were 
identified as PIE-1 protein interactors in this screen (Table 2.2). The failure to 
identify E1 SUMO activation enzyme is consistent with its known function in 
binding SUMO proteins but not substrates (Gareau and Lima, 2010). This result 
implies that PIE-1 function may be dependent on SUMOylation, because all 
SUMO components that can bind to a protein substrate were identified in this 
screen. 
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Table 2.2 PIE-1 interactors identified in yeast two-hybrid screen 
The score that was computed to assess interaction reliability represents the 
probability of non-specific interaction. A is the lowest probability and E is the 
highest probability. 
Gene Domain/function Score 
ZIF-1 ZF interacting protein/ubiquitination A 
GEI-17 E3 ligase for sumo A 
GLD-3 KH domain/Germ line development B 
MBL-1 MUSCLEBLIND-mRNA splicing regulator B 
PIE-1 Probable homodimer B 
POP-1 TCF family member/posterial pharynx defect B 
LON-1 PR-protein superfamily/ a target of TGF beta family B 
SMO-1 SUMO C 
UBC-9 E2 ligase for sumo E 
MEP-1 C2H2/function with NuRD complex E 
RAD-26 An ortholog of human RAD54L2 A transcription-coupled repair factor E 
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We next analyzed genetic interactions between pie-1 and smo-1, ubc-9, 
and gei-17 to investigate whether SUMOylation facilitates PIE-1 function. 
Depletion of smo-1, ubc-9, or gei-17 by RNAi resulted in the death of all the 
progeny of wild-type animals during embryogenesis, but the dead embryos 
showed low penetrance extra intestinal cells derived from the germline 
blastomere, a phenotype similar to the pie-1 null mutant (Figure 2.1A). RNAi of 
these genes caused pie-1 heterozygotes to make high penetrance dead embryos 
with the pie-1 mutant phenotype (Figure 2.1A), suggesting that SUMOylation is 
required for PIE-1 function.  
 
Generation of temperature-sensitive ubc-9 alleles and analysis of genetic 
interaction between pie-1 and ts ubc-9  
For a detailed genetic study of SUMOylation with pie-1, we aimed to generate 
temperature-sensitive (ts) ubc-9 alleles by CRISPR/Cas9-mediated genome 
editing, because the homozygous ubc-9 deletion allele (tm2610) showed strong 
zygotic effect-sterility. Previously, a ts Ubc9 allele (P69S) was generated in the 
yeast Saccharomyces cerevisiae by mutating a conserved proline residue across 
other members of the Ubc protein family (Betting and Seufert, 1996). We were 
also able to find the conserved proline residue in the C. elegans UBC-9 protein 
as the UBC-9 protein sequence is highly homologous to yeast UBC9 (94%). The 
newly generated ubc-9 (P69S), however, showed a strong sterile phenotype like 
the null allele at 20°C although the strain was fertile, but produced dead embryos 
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at 15°C. The G56 residue corresponds to another identified ts allele, G58 in 
yeast Cdc34 (Prendergast et al., 1995), which is also conserved in all UBC 
proteins across other organisms (Figure 2.1B). Using CRISPR/Cas9-mediated 
genome editing, we successfully generated the ts mutant ubc-9 (G56R) (Figure 
2.1C) that has a wild-type appearance at 15°C but produces 100% dead 
embryos at 25°C (Figure 2.1A). Employing the ts mutants of C. elegans, we 
asked whether the ubc-9 homozygous strain while pie-1 heterozygous, produces 
dead embryos with a pie-1 phenotype (extra intestine). The occurrence of a pie-1 
phenotype was significantly increased in ubc-9 (G56R); pie-1/+ mutants 
compared to ubc-9 (G56R) mutants at 25°C (Figure 2.1A). However, we noticed 
that ts ubc-9 mutants in pie-1 heterozygotes (25°C) showed a lower penetrance 
pie-1 phenotype than after ubc-9 RNAi (20°C) (Figure 2.1A). One possibility is 
that among the target proteins of UBC-9 may be ts genes that cause a different 
phenotype from ubc-9 RNAi. Considering that RNAi-mediated depletion usually 
does not completely shut off the target gene, another possible explanation is that 
ubc-9 (G56R) at 25°C can completely remove functional UBC-9 protein, whereas 
using RNAi depletes UBC-9 partially, thereby causing ubc-9(G56R) (25°C) 
mutation to gives rise to a phenotype more biased towards the ubc-9 mutant than 
ubc-9 RNAi. 
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Figure 2.1 Genetic interactions between pie-1 and smo-1, ubc-9, and gei-17 
(A) Genetic interaction of pie-1 with SUMOylation pathway. Defective SUMOylation 
pathway by RNAi feeding-mediated each indicated gene knockdown causes high 
frequency of pie-1 dead embryos at 20°C. The ubc-9(G56R) ts allele makes 2-fold 
increased pie-1 dead embryos at 25°C, but shows a lower penetrance extra gut derived 
from the germline blastomere compared to RNAi feeding experiments. (B) Partial 
sequence alignment of UBC enzymes including UBC9. Residues conserved in all UBC 
proteins are shown in red. The indicated G56 and P69 residues are isolated ts alleles in 
yeast Cdc34 and both are conserved in all UBC proteins over other organisms (blue 
box). Among many conserved residues, the G56 residue is identified as a ts allele in C. 
elegans. (C) Schematic of the Cas9/sgRNA target sites in ubc-9 locus and donor 
plasmid. The G56R donor contains ~400 bp of homology flanking the PAM site (green 
box) and introduces a HaeIII (by codon substitution) and BstBI (by mutation in the seed 
region) restriction sites (red box). The blue bar indicates the PAM site, and the red bar 
indicates the position of G56.    
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PIE-1 mislocalization in SMO-1-depleted oocytes 
As implied by the analysis of genetic interactions, if SUMOylation regulates PIE-1 
function in germline specification, PIE-1 protein stability or localization in the 
germline lineage might be affected by SMO-1 depletion. Alternatively, 
SUMOylation might regulate PIE-1 at the molecular levels, such as inducing PIE-
1 conformational changes to facilitate or inhibit interactions with its binding 
partners. To assess these possibilities, we first examined PIE-1 localization in 
previously generated pie-1::gfp CRISPR lines (Kim et al., 2014). The dynamic 
distribution of PIE-1 in the early embryos has already been well studied. As 
expected, embryonic localization of PIE-1::GFP in the CRISPR lines was 
consistent with previous findings that PIE-1 is present in the nuclear and 
cytoplasmic P-granule of the germline blastomeres (Figure 2.2A) (Mello et al., 
1996; Reese et al., 2000; Tenenhaus et al., 1998). In the adult germline, 
however, we observed that PIE-1 localization was different from the previous 
reports of PIE-1 detection in the cytoplasm of oocytes both using a monoclonal 
antibody (Tenenhaus et al., 1998) and by generating transgenic lines using the 
complex array method (Reese et al., 2000). PIE-1 protein was first detected in 
pachytene nuclei at low levels but gradually increased throughout the germline 
development until fertilization (Figure 2.2A). We also observed PIE-1 in the nuclei 
of oocytes where the PIE-1 expression pattern appears to be associated with 
DNA (Figures 2.2A and 2.2B).  
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We then examined if smo-1 RNAi causes PIE-1 mislocalization. In oocytes 
depleted of SMO-1 by RNAi, we observed that PIE-1 was obviously sequestered 
in the nucleolar structure (Figures 2.2B and 2.2C), suggesting that proper PIE-1 
localization requires SUMOylation. The oocytes with the sequestered PIE-1 in 
the nucleolus were fertilized normally, but embryonic lethality followed. Unlike in 
the oocytes, we did not observe an obvious difference in the nuclear localization 
of PIE-1 between the control and SMO-1-depleted embryos, except that the 
punctate cytoplasmic expression of PIE-1 in P-granules appeared mildly 
diminished at the P2 blastomere in SMO-1-depleted embryos (data not shown). 
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Figure 2.2 PIE-1 expression in the adult germline 
(A) Confocal images of adult germline and embryos in a strain expressing PIE-1::GFP. 
(B) Confocal images of adult germline expressing PIE-1::GFP either without (L4440) or 
with smo-1(RNAi). (C) Nomarski DIC and GFP fluorescence micrographs of oocytes in 
SMO-1-depleted adults by RNAi. The white arrow indicates the PIE-1 expression in the 
nucleoli.  
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PIE-1 is SUMOylated on lysine 68 residue in the C. elegans germline  
We then asked whether PIE-1 is indeed SUMOylated in C. elegans. 
PIE-1 contains only one consensus SUMO acceptor site, consisting of the 
sequence ψKXE (Figure 2.3A) where SUMOylation usually occurs (Rodriguez et 
al., 2001). These residues are perfectly conserved in C.briggsae and C. elegans 
(data not shown). Thus, we investigated whether the consensus SUMO acceptor 
site is required for PIE-1 SUMOylation if PIE-1 is SUMOylated. To perform an in 
vivo SUMO purification assay in C. elegans, we generated an endogenously 
tagged his10::smo-1 CRISPR strain (Figure 2.3B) that allows SUMO-modified 
proteins to be enriched by nickel affinity chromatography under denaturing 
conditions. Purification under denaturing conditions improves detection of 
SUMOylated proteins at levels similar to that of the endogenous protein by 
removing non-covalent interactions and inhibiting SUMO-specific protease 
activity (Tatham et al., 2009). Previously generated wild-type pie-1::flag and the 
consensus SUMO acceptor site mutant pie-1(K68R)::flag CRISPR alleles using 
each plasmid donor (Figure 2.3C) (Kim et al., 2014) were introduced into 
his10::smo-1 CRISPR lines by genetic mating, because the PIE-1 antibody 
(P4G5) is not effective for detecting PIE-1 SUMOylation. This is because the 
peptide used to make P4G5 antibody contains amino acids 54–73 which include 
a potential SUMO-binding site, K68 (Mello et al., 1996; Tenenhaus et al., 1998) 
and we observed that the P4G5 antibody no longer recognized PIE-1 protein 
when we engineered a strain expressing a single copy of the genomic fusion 
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gfp::pie-1(K68R) transgene (data not shown) (Frokjaer-Jensen et al., 2008). We 
also created a multiple epitope, GFP::TEV (a TEV protease cleavage site, 
ENLYFQG)::3xFlag, tagged mep-1 CRISPR line using a plasmid donor (Figure 
2.3D) for further functional studies of PIE-1, because PIE-1 directly interacts with 
the MEP-1 and NuRD complex (Unhavaithaya et al., 2002). SUMO purification 
followed by western blotting revealed a slowly migrating PIE-1 band that 
represents the SUMOylated PIE-1 in his10::smo-1; pie-1::flag, but not in 
his10::smo-1; pie-1(K68R)::flag (Figure 2.3F). The SUMOylated PIE-1 band, 
however, was detected only in adult lysates and not in embryo lysates, whereas 
the SUMOylated MEP-1 band was present in both lysates (the SUMOylated 
MEP-1 was used as a positive control of SUMO purification after confirming 
SUMO is conjugated to MEP-1 in both lysates) (Figures 2.3E and 2.3F). Taken 
together, these data suggest that PIE-1 is indeed a SUMO substrate and the 
lysine 68 residue is a crucial site for PIE-1 SUMOylation. In addition, PIE-1 
SUMOylation appears to occur in the germline before fertilization. 
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Figure 2.3 PIE-1 is SUMOylated on K68 residue in the C. elegans germline 
(A) Schematic of PIE-1 containing the consensus SUMO acceptor site (ψKXE), K68. The 
black bars represent lysine residues on PIE-1 and the K68 is indicated with red bar. (B) 
Schematic of the his10::smo-1 donor plasmid. The 10xhis coding sequence is inserted 
immediately after the smo-1 start codon. (C). Schematic of the pie-1 donors used to 
generate either pie-1(K68), pie-1::flag, or pie-1(K68R)::flag. (D) Schematic of the mep-
1::gfp::tev::flag donor plasmid 
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(Figure 2.3 continued)  
(E) In vivo SUMO purification assay followed by western blotting in embryo lysates. PIE-
1 SUMOylation is not detected while MEP-1 SUMOylation is detected (arrow). (F) In vivo 
SUMO purification assay followed by western blotting in adult lysates revealed 
endogenously SUMOylated PIE-1 and the K68R abolished PIE-1 SUMOylation (arrow). 
HDA-1 SUMOylation was detected, but dependent on the K68 residue (arrow). 
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SUMO acceptor site mutant pie-1(K68R) has a weak hypomorphic 
phenotype 
Although pie-1(K68R) mutant animals were completely devoid of PIE-1 
SUMOylation (Figure 2.3F), the functional consequence of PIE-1 SUMOylation 
seemed to be different from that suggested by our genetic interactions data 
because pie-1(K68R) mutants did not produce dead embryos like the pie-1 null 
mutants (Figures 2.1A and 2.4B). One possible explanation is that the functional 
effect of PIE-1 SUMOylation on germline specification can be more critical when 
PIE-1 levels are low, like in the case of heterozygous pie-1/+. Consistent with this 
hypothesis, when we generated single-copy pie-1 transgenes (Frokjaer-Jensen 
et al., 2008), gfp::pie-1 and gfp::pie-1(K68R), where PIE-1 expression level is 
lower than in endogenously tagged CRISPR line (Kim et al., 2014), the gfp::pie-
1(K68R) poorly rescued a putative pie-1 null mutant (zu154) at 5%(n=1250), 
while the wild-type gfp::pie-1 transgene rescued at 93% (n=1222) (data not 
shown). Alternatively, when PIE-1 levels were normal, the defective phenotype of 
PIE-1 SUMOylation appeared weak as shown in the pie-1(K68R) CRISPR line. In 
addition, our finding that PIE-1 is present in the nucleus of adult germline cells 
suggests that PIE-1 functions not only in the germline specification for 
embryogenesis but also in genomic stability. Thus, we sought to extensively 
characterize the pie-1(K68R) mutant phenotype. Interestingly, we detected a 
notable frequency of diverse abnormal phenotypes while propagating the pie-
1(K68R), such as high incidences of males (him), burst worms, tail 
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morphogenesis, or sterility (data not shown). To exclude a possibility of 
mutations caused by off-target effects of CRISPR/Cas9-mediated genome 
editing, we outcrossed the pie-1(K68R) strain several times and compared the 
resultant lies to other independently generated pie-1(K68R) CRISPR lines. We 
confirmed that 5% of adult progeny displayed different spontaneous mutations in 
the outcrossed pie-1(K68R) (n=6880, data not shown), while this percentage is 
normally 0.1–0.2% for wild-type (Ahmed and Hodgkin, 2000; Harris et al., 2006; 
Hodgkin et al., 1979), indicating that the effect we observed in pie-1(K68R) was 
not due to off-target effects. Moreover, the brood sizes of individual pie-1(K68R) 
mutants were notably variable, although the average number of progeny did not 
show a significant difference compared to wild-type (Figure 2.4A). Interestingly, 
the size of the pie-1(K68R) gonad was obviously smaller than that of wild-type 
and the number of germ cells was also lower than in wild-type (Figure 2.4C). 
The SUMOylation pathway has been suggested to activate DNA damage 
responses (Boulton et al., 2004; Holway et al., 2006; Kim and Colaiacovo, 2015; 
Kim and Michael, 2008; Reichman et al., 2018). Therefore, loss of functional 
SUMO in the pie-1(K68R) mutant should result in a more severe defect in 
genome stability if PIE-1 SUMOylation is indeed crucial for protecting the 
genomic integrity of the germline. 3xflag::smo-1 CRISPR lines, unexpectedly, 
displayed a hypomorphic mutation phenotype including a high rate of male 
progeny, embryonic lethality, and L1 lethality. We observed a significantly 
reduced brood size when we introduced a pie-1(K68R) hypomorphic allele into 
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the 3xflag::smo-1 strain by crossing, compared to each single mutant, whereas 
there was no detectable genetic interaction in embryonic lethality (Figures 2.4A 
and 2.4B).  
We further tested the genetic interactions of pie-1(K68R) with another 
crucial factor for genome stability. A beta-nucleotidyl transferase RDE-3/MUT-2, 
one of the downstream factors in the RNAi pathway, is required for genome 
stability based on its silencing of transposons and high-copy number transgenes 
(Chen et al., 2005; Collins and Anderson, 1994). Interestingly, pie-1(K68R) 
showed strong genetic interactions with rde-3; for example, the rde-3(ne3370); 
pie-1(K68R) showed a 100% sterile phenotype (data not shown). A germ cell 
nuclear antigen (GCNA) protein that is homologous to IDR-containing proteins 
implicated in DNA damage repair is required for genome integrity (G, Dokshin, 
personal communication) (Carmell et al., 2016). In C. elegans, two independent 
deletion mutants, gcna-1(ne4334) and gcna-1(ne4356), were generated using 
CRISPR/Cas9-mediated genome editing (Carmell et al., 2016). Consistent with 
the idea that PIE-1 SUMOylation may play a role in protecting germline integrity, 
we observed a dramatically increased sterile phenotype both in pie-1(K68R), 
gcna-1(ne4334) and in pie-1(K68R), gcna-1(ne4356), while each gcna-1 mutant 
alone did not show an apparent phenotype (data not shown). Taken together, 
these data suggest that PIE-1 SUMOylation is involved in genome stability. The 
state of genome stability in the adult germline may affect gamete production, 
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which results in the failure to protect the germline lineage after fertilization in a 
pie-1 dosage-dependent manner.  
To further investigate the effect of PIE-1(K68R) on germline specification 
in embryos, we compared PIE-1 expression patterns in the wild-type and K68R 
mutant. We did not detect any apparent differences between them. However, 
PIE-1 expression in the P-granule was gradually diminished during 
embryogenesis (from P2 to P4) in the K68R mutant, but not in the wild-type 
(Figures 2.4D and 2.4E). 
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Figure 2.4 Characterization of pie-1(K68R) 
(A) Brood sizes and (B) Embryonic lethality of N2, pie-1(K68R), 3xflag::smo-1, and 
3xflag::smo-1; pie-1(K68R). Two-tailed t-test: ***P<0.0005, ****P<0.00001. (C) 
Immunofluorescence micrographs of DAPI in adult gonad of WT and K68R. 
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(Figure 2.4 continued) 
(D) and (E) Confocal images of embryos expressing PIE-1::GFP (in WT and K68R as 
indicated) and PGL-1::mCherry, and confocal immunofluorescence micrographs of anti-
NPP-9 and DAPI.  
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PIE-1 SUMOylation facilitates HDA-1 SUMOylation 
Given our genetic data and the functional consequence of PIE-1 SUMOylation, 
we asked whether the genome instability of pie-1(K68R) involves regulation of a 
PIE-1–dependent NuRD complex. Our previous studies suggested that PIE-1 
inhibits the activity of the MEP-1 and NuRD complex, including LET-418/Mi-2 and 
HDA-1/HDAC-1, to protect the MES-dependent germline chromatin state during 
the early embryogenesis (Unhavaithaya et al., 2002). SUMOylation promotes 
binding of multiple functionally related proteins by acting as a ‘SUMO glue’ 
(Matunis et al., 2006; Shen et al., 2006), and functionally related proteins are 
SUMOylated together (Golebiowski et al., 2009; Psakhye and Jentsch, 2012; 
Tammsalu et al., 2014; Tatham et al., 2011). Therefore, PIE-1 SUMOylation also 
may facilitate SUMOylation of MEP-1, LET-418, or HDA-1. Using a well-validated 
antibody for HDA-1 detection, we easily detected a slowly migrating HDA-1 band 
in animals having the his10::smo-1 allele, which indicates the presence of a 
SUMOylated HDA-1(Figure 2.3F). Surprisingly, the level of SUMOylated HDA-1 
was significantly reduced only in the SUMO acceptor site mutant pie-1(K68R) 
(Figure 2.3F), supporting our hypothesis that PIE-1 SUMOylation may enhance 
SUMOylation of a PIE-1 binding partner. However, MEP-1 SUMOylation was not 
affected by defective PIE-1 SUMOylation (data not shown) and it was technically 
impossible to determine whether LET-418 is SUMOylated because the size of 
unmodified LET-418 is already too big (~250 kDa) for the protein to be detected 
and distinguished from SUMOylated LET-418. 
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Next, we addressed whether PIE-1 SUMOylation requires the formation of 
the functional NuRD complex. However, we encountered technical issues in PIE-
1 IP, including the insolubility of nuclear PIE-1 proteins in lysis buffer, the lack of 
an available PIE-1 antibody that recognizes peptides outside of the SUMO 
acceptor site, and an epitope tag-cleavage issue during the IP process. In MEP-1 
IP, we confirmed previous findings that MEP-1 interacts with the NuRD complex 
in embryo lysates (Figure 2.5A) (Unhavaithaya et al., 2002). However, as 
reported previously (Unhavaithaya et al., 2002), PIE-1 was not detected in MEP-
1 IP (data not shown). Perhaps, detection of PIE-1 protein is challenging due to 
the insolubility of PIE-1. The interaction between MEP-1 and the NuRD complex 
was still intact in embryos of pie-1(K68R) mutants (Figure 2.5A). As our SUMO 
purification data suggested that PIE-1 SUMOylation occurs in the adult germline 
before fertilization, we further investigated their interactions in adult lysates. In 
contrast to embryos, HDA-1 was not bound to MEP-1 in adults of pie-1(K68R) 
mutants, while the levels of LET-418 bound to MEP-1 were not changed (Figure 
2.5B). Therefore, these data suggest that PIE-1 SUMOylation is required for 
HDA-1 SUMOylation, which is an essential step in the formation of a functional 
NuRD complex in the adult germline.  
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(Figure 2.5 continued) 
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Figure 2.5 PIE-1 SUMOylation is required for activity of histone deacetylase 
(A) and (B) Co-immunoprecipitation experiment showing physical interaction between 
MEP-1 and NuRD complex (LET-418 and HDA-1). Immunoprecipitation was performed 
in embryo and adult lysates using GBP beads, and the indicated proteins (MEP-1, LET-
418, and HDA-1) were detected with anti-FLAG antibody, anti-LET-418 antibody, and 
anti-HDA-1 antibody, respectively. (C) Immunofluorescence micrographs of anti-H4ac 
and anti-H3K9me3 double staining in adult oocytes of WT and the K68R mutant. (D) 
Immunofluorescence micrographs of anti H3K9Ac and anti-H3K9me3 double staining in 
adult oocytes of WT and the K68R mutant. The arrows indicate stained chromosomes 
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Increased levels of histone acetylation in pie-1(K68R) 
SUMOylation of HDAC1 has been proposed to enhance both its activity and its 
role in transcriptional repression (Cheng et al., 2004; David et al., 2002; Gill, 
2005). On the other hand, HDAC1 SUMOylation enhances the expression of an 
anti-apoptotic gene by releasing a transcription factor (Tao et al., 2017). 
Interestingly, intermediate functions of HDAC1 SUMOylation were also reported 
(Citro et al., 2013; Joung et al., 2018). For example, basal level of SUMOylated 
HDAC1 represses a transcription factor MyoD, but enhanced HDAC1 
SUMOylation changes its binding partners for myogenesis from MyoD to E2F/RB 
(Joung et al., 2018). These discrepant previous results may imply that the 
function of HDAC SUMOylation is highly dependent on the physiological context. 
Given our findings that unSUMOylated HDA-1 did not associate with MEP-1 or 
LET-418, the NuRD complex may lose its role in transcriptional repression due to 
increased acetylation level. To test this possibility, we examined histone 
acetylation levels in the adult germline. In the oocytes, we observed visibly 
increased acetylation levels of both H4 and H3K9 in the pie-1(K68R) mutant 
compared to wild-type (Figures 2.5C and 2.5D), suggesting that decreased HDA-
1 SUMOylation and thus loss of NuRD complex formation represses the histone 
deacetylase activity of HDA-1.  
Many studies have suggested that HDACs play an important role in DNA 
damage responses by maintaining chromatin structure during DNA repair, 
inhibiting transcription in the repair region, or directly regulating the important 
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repair factors (Dobbin et al., 2013; Gong and Miller, 2013; Hsiao and Mizzen, 
2013; Miller et al., 2010; Nikolova et al., 2017; Stengel and Hiebert, 2015). As a 
consequence of HDAC inhibition, accumulation of double-strand breakes, 
enhanced apoptosis, and genomic instability have been reported (Nikolova et al., 
2017; Robert and Rassool, 2012; Thurn et al., 2013). The phagocytic receptor 
cell death abnormal 1 (CED-1) is a component of the apoptotic pathway and 
initiates a signaling pathway for engulfment of apoptotic cells in C. elegans (Yu et 
al., 2008; Zhou et al., 2001). Therefore, we examined whether pie-1(K68R) 
increases the number of apoptotic cells in the adult germline. Interestingly, pie-
1(K68R) mutant gonads displayed a 2-fold increase in CED-1::GFP-expressing 
cells that represent engulfing cells undergoing apoptosis (Lu et al., 2009; Zhou et 
al., 2001), compared to wild-type (Figures 2.6A and 2.6B). In addition, we 
detected that 3% of scored gonads (n=155) in the distal tip of pie(K68R) 
contained an abnormally high number of apoptotic cells, whereas the wild-type 
did not show any apoptosis in the distal tip (0%, n=109, Figures 2.6A and 2.6B). 
These findings strongly support our idea that the increased number of apoptotic 
cells and genomic instability in the pie-1(K68R) mutant may be due to HDA-1 
inhibition by loss of SUMOylation. 
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Figure 2.6 Increased number of apoptotic cells in the adult gremlin of pie-1(K68R). (A) 
GFP fluorescence micrographs of adult germline expressing CED-1::GFP, an apoptosis 
marker, to show an example image in WT and pie-1(K68R). In the K68R mutant, most 
germ cells in the distal tip express CED-1 ::GFP in 3% of scored gonads (5/155). (B) The 
quantification of the number of apoptotic cells using CED-1 GFP per gonad arm. The 
square bracket indicates animals showing a higher number of apoptotic germ cells in the 
distal tip. Two-tailed t-test: ****P<0.0001. 
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Discussion 
The results of the present study demonstrate that PIE-1 protein is a SUMO 
substrate, and their interaction is required for NuRD complex formation and the 
activity of histone deacetylase in the C. elegans germline. We found that PIE-1 
protein was present in the nuclei of pachytene-stage germ cells and oocytes in 
the adult germline, implying that PIE-1 may function in meiotic progression of 
germ cells. Our in vivo SUMO purification assay revealed that PIE-1 was 
SUMOylated in the adult germline, but not in embryos, and the K68 residue of 
PIE-1 was a SUMO acceptor site. The SUMO acceptor site mutant pie-1(K68R) 
decreased HDA-1 SUMOylation and abolished MEP-1 interaction with the NuRD 
complex. In addition, depletion of PIE-1 SUMOylation caused an increase in the 
number of apoptotic germ cells in the pachytene region, and occasionally, most 
mitotic germ cells underwent apoptosis in the pie-1(K68R) mutant. In conclusion, 
our study suggests that a novel function of PIE-1 in the adult germline is to 
protect a NuRD complex-mediated epigenetic state required for genome stability, 
which may affect germline specification after fertilization.   
Our genetic experiments suggest that SUMOylation is required for PIE-1 
functions in germline specification during embryogenesis. In contrast to this 
strong genetic interaction data, the SUMO acceptor mutant pie-1(K68R), 
however, resulted in a very mild phenotype at a glance. Like with the pie-1(K68R) 
mutation, mutation of most SUMO substrates has resulted in no notable 
phenotype, and thus, the functional consequences of their SUMOylation remain 
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enigmatic. Recently, a reasonable explanation for the paradoxical discrepancy 
between the strong phenotype of SUMO pathway mutants and the mild 
phenotype of a single SUMO substrate mutant has been proposed: SUMOylation 
targets a functional protein group rather than one specific protein, and thus, the 
SUMOylated proteins act together to trigger synergistic effect on an important 
biological function (Golebiowski et al., 2009; Psakhye and Jentsch, 2012; 
Tammsalu et al., 2014; Tatham et al., 2011). Therefore, if we could identify and 
mutate all SUMO substrates in the same functional group with PIE-1, we might 
detect a strong phenotype like that of the pie-1 null mutant. Our current results at 
least indicate that HDA-1 is a factor in the same functional group as PIE-1 in the 
C. elegans germline. 
In contrast to our finding that histone acetylation levels are increased in 
the pie-1(K68R) mutant compared to the wild-type, PIE-1 has been suggested 
previously to inhibit HDA-1 activity (Unhavaithaya et al., 2002). In addition, 
ectopic overexpression of PIE-1 (via the heat-shock promoter, hsp16-1, 
(Seydoux et al., 1996)) in somatic tissues induces a synMuv phenotype like the 
mep-1 mutant phenotype in a lin-15A background, suggesting that PIE-1 
antagonizes the MEP-1 and NuRD complex (Unhavaithaya et al., 2002). 
However, an engineered strain expressing a single-copy hsp::pie-1 (Frokjaer-
Jensen et al., 2008) did not show any synMuv phenotype, although 
overexpression of PIE-1 was confirmed by western blotting (data not shown). 
Thus, we were concerned that the result previously reported by Unhavaithaya et 
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al. might have been obtained due to random integration of extrachromosomal 
array hsp::pie-1 into an unknown genomic region that disrupts a functional gene. 
Nevertheless, our genetic data still appear to support the previous model that 
PIE-1 protects the germline fate from MEP-1 and NuRD complex–induced 
chromatin remodeling by antagonizing the MEP-1 and NuRD complex. For 
example, the pie-1(K68R) mutation suppressed ~26% of the L1 lethality caused 
by mep-1 loss of function (data not shown). One possible model is that the 
functions of PIE-1 differ between the adult germline and the germline 
blastomeres of zygotic embryos, and these different functions are regulated by 
the SUMOylation pathway. Alternatively, the integrity of the adult germline may 
affect germline specification in the embryos. Therefore, we propose that in the 
adult germline, PIE-1 SUMOylation is required for the formation of a functional 
NuRD complex to create proper epigenetic information before fertilization, which 
is required for inhibiting somatic gene transcription after fertilization, and to 
protect genomic stability from DNA damage by facilitating HDA-1 SUMOylation 
(and SUMOylation of possibly other proteins), which is required for a DNA repair 
pathway.  
Considering our finding that the pie-1(K68R) mutant shows an increased 
level of histone acetylation, we will prioritize studies to determine whether loss of 
PIE-1 SUMOylation affects transcription in the germline. In addition, if we 
determine and mutate a SUMO acceptor site of MEP-1, HDA-1, or another 
possible component in the same functional group, we will be able to address 
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whether they act together with PIE-1 to trigger a synergistic effect on germline 
specification in the embryos. 
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CHAPTER III: GENERATION OF pie-1(DAQMEQT)::gfp CRISPR LINES AND 
IN VIVO MODEL STUDY FOR TRANSCRIPTIONAL REGULATION  
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Introduction 
In C. elegans, maternally loaded PIE-1 functions as a crucial germline 
determinant during early embryogenesis (P1–P4). PIE-1 depletion causes P2 
germline blastomere to adopt the fate of its sister blastomere, EMS (Mello et al., 
1992). This dramatic transformation of cell fate has been an intriguing subject of 
investigations to understand how animals protect their germline lineages from 
inappropriate somatic differentiation. Seydoux et al first found that mRNA 
transcription is silenced in the early germline blastomere (Seydoux et al., 1996). 
In addition, Ser2 phosphorylation of a pol II elongation marker is not detected in 
the early germline blastomeres but appears when pie-1 is absent (Seydoux and 
Dunn, 1997). Studies using a human cell culture system suggested that PIE-1 
contains a mimic sequence (YAPMAPT) that resembles the heptapeptide repeat 
sequence (YSPTSPS) of pol II CTD, where phosphorylation occurs for elongation 
(Ser2) and initiation (Ser5), and thus, PIE-1 competitively targets and sequesters 
CTD kinase away from pol II (Batchelder et al., 1999). In addition, the YAPMAPT 
mutation (DAQMEQT) rescues the pie-1 null allele at a reduced frequency 
compared to wild-type (Batchelder et al., 1999), indicating that the YAPAMPT 
sequence is important for PIE-1 functions.  
Previously, a strain engineered to carry a single copy or low copy number 
of DAQMEQT transgenes via ballistic transformation was used to test the 
importance of the YAPMAPT sequence in transcriptional repression (Ghosh and 
Seydoux, 2008). However, studies using these transgenes suggested that the 
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YAPMAPT motif is essential for inhibition of Ser2 phosphorylation but not for 
transcriptional repression (Ghosh and Seydoux, 2008). We can now introduce 
the transgene at an endogenous locus using CIRSPR/Cas9-mediated genome 
editing, which allows us to monitor the mutant phenotype in the biological 
context.  
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Results 
We generated the DAQMEQT CRISPR lines to explore the mechanism by which 
PIE-1 functions in germline specification as demonstrated in the previous studies. 
We also introduced either GFP or FLAG epitope tag to the C terminus of the PIE-
1 genomic locus, thereby creating pie-1(DAQMEQT)::gfp and pie-
1(DAQMEQT)::flag. The DAQMEQT mutant showed a maternal-effect sterile 
phenotype at a high frequency (72%) but not embryonic lethality like a pie-1 null 
phenotype (Figure 3.1A). For the most part, the P2 blastomere was properly 
specified with little sign of cell fate change as expected from a pie-1 null allele. 
Because the YAPMAPT sequence was proposed to be a competitive non-
phosphorylatable inhibitor of CTD kinase (Batchelder et al., 1999), we reasoned 
that lowering CDK12 activity might suppress the DAQMEQT mutant. While the p-
TEFb complex, CDK-9/cyclin T, has been thought to be required for CTD Ser2 
phosphorylation (Ghosh and Seydoux, 2008; Wood and Shilatifard, 2006; Zhang 
et al., 2003), another Ser2 kinase complex, CDK-12/cyclin K was identified in C. 
elegans, Drosophila, and human (Bartkowiak et al., 2010; Bowman et al., 2013). 
In the C. elegans germline, Ser2 phosphorylation requires CDK-12, but not CDK-
9 (Bowman et al., 2013). To test this possibility we used a cdk-12-analog-
sensitive (-as) allele that has a single amino acid mutation (F383G) in the ATP- 
binding pocket created by CRISPR/Cas9-mediated genome editing (gift from 
Hermand Damien, University of Namur, Belgium). The as allele can bind to a 
bulky ATP analog, thereby blocking kinase activity when an ATP analog drug is 
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added (Lera and Burkard, 2012). Strikingly, we found that even without the drug, 
the homozygous cdk-12-as pie-1(DAQMEQT)::gfp showed a significantly 
suppressed sterile phenotype to 2% (instead of 72% in the DAQMEQT) (Figure 
3.1A), strongly supporting the previous model that the YAPMAPT motif is 
responsible for the inhibition of CTD kinase. With drug treatment, cdk-12-as 
showed a fully penetrant L1 arrest phenotype like cdk-12 (RNAi). The DAQMEQT 
mutant also caused significant suppression of larval arrest as with the cdk-12-as 
allele. Instead of only 2% of cdk-12-as mutants escaping and reaching adulthood 
after treatment with the 1µM ATP analog dose, we found that 23% of the cdk-12-
as, pie-1(DAQMEQT)::gfp animals reached adulthood. These findings clearly 
suggest a relationship between PIE-1 and CDK-12.  
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Figure 3.1 Genetic interaction between pie-1(DAQMEQT)::gfp and cdk-12-as  
(A) cdk-12-as allele suppresses a sterile phenotype of the DAQMEQT mutant. (B) The 
DAQMEQT mutant rescues L1 arrest phenotype of cdk-12-as in 1 µM of ATP-analog 
drug, 3MB-PP-1 (Toronto Research Chemicals, A602960). 100 µM of stock solution was 
prepared in DMSO and added to the NGM agar before pouring plate and OP50 
containing 1 µM of ATP-analog drug was seed to the plates. Synchronous L3-L4 
animals were placed to the NGM plate containing 1µM of ATP-analog drug.  
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Accordingly, we expected that Ser2 phosphorylation would be altered in 
the DAQMEQT mutant as previously published (Ghosh and Seydoux, 2008). The 
antibody we used (3E10) is well known to be specific for pol II in C. elegans 
(Bowman et al., 2013; Furuhashi et al., 2010). As expected, we observed that 
significantly reduced Ser2 phosphorylation in cdk-12 (RNAi) embryos using this 
antibody (Figure 3.2C) (Bowman et al., 2013). However, unexpectedly we could 
not find any significant difference between germline blastomeres and somatic 
blastomeres on immunostaining using this Ser2 phosphorylation-specific 
antibody in the wild-type embryos (Figure 3.2A).  
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Figure 3.2 Ser2 phosphorylation staining in germline blastomeres  
Confocal fluorescence micrographs of embryos expressing (A) PIE-1::GFP, (B) PIE-
1(DAQMEQT)::GFP, and (C) PIE-1::GFP in cdk-12(RNAi) and confocal 
immunofluorescence micrographs of anti-Ser2P in (A) pie-1::gfp, (B) pie-
1(DAQMEQT)::gfp, and (C) pie-1::gfp; cdk-12(RNAi). 
 
 
P-Ser2 DAPI PIE-1 Merge 
pie-1(WT)::gfp; cdk-12(RNAi)
C
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In the germline blastomere, as in all cells, we observed pronounced cell 
cycle–dependent regulation of the nuclear epitope detected by this antibody. The 
immunostaining signals from antibodies was dispersed in the cytoplasm during 
nuclear breakdown and then became brighter gradually in the newly formed 
daughter nuclei over time (Figure 3.3) These findings raise concern that the 
previous claims could have been mistaken due to a timing issue, as the germline 
blastomere divides slower. For example, if we observed enough embryos, we 
found that the germline blastomeres were dimmer than their sisters due to this 
timing difference (Figure 3.3).  
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Figure 3.3 Ser2 phosphorylation staining is dependent on cell cycle 
Confocal fluorescence micrographs of PIE-1::GFP and confocal immunofluorescence 
micrographs of anti-Ser2P from 4cell embryos to 12 cell embryos. 
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Discussion 
While our immunofluorescence results detecting Ser2 phosphorylation in the 
wild-type germline blastomeres is controversial due to a discrepancy with a large 
body of evidence accumulated over the last 20 years, another CRIPSR strain 
expressing PIE-1(R109L)::GFP, an escape from ZIF-1 target, appears to support 
our observations. ZIF-1 interacts with CCCH finger proteins including PIE-1 to 
degrade them in somatic cells (DeRenzo et al., 2003). While the first CCCH zinc 
fingers (ZF1s) from PIE-1, MEX-1, and POS-1 and ZF2 from MEX5 have been 
identified as ZIP target proteins (DeRenzo et al., 2003), a critical residue in the 
ZF domain that requires this interaction remains to be determined. In an attempt 
to find the important residue, we aligned all ZF domains and identified the R109 
residue as conserved among the ZIF-1–interacting domains above, but not in 
non-ZIF-1 target regions (data not shown). pie-1(R109L)::gfp mutants showed 
PIE-1 expression in the nuclei of somatic blastomeres (data not shown), 
indicating the R109 is an important residue for ZIF-1 targeting. However, the 
somatic expression of PIE-1 did not impair embryogenesis at all, and we did not 
detect any defect throughout animal development, which is not consistent with 
the embryonic lethal phenotype of zif-1(RNAi) (DeRenzo et al., 2003) and an 
idea that PIE-1 represses transcription globally.  
Nevertheless, based on previous in situ hybridization studies (Seydoux et 
al., 1996), germline blastomeres definitely exhibit limited transcription compared 
to somatic blastomeres and pie-1–depleted germline blastomeres. Moreover, in 
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our genetic interaction investigation between cdk-12 and the DAQMEQT mutant, 
a mutually rescuing result strongly suggested that PIE-1 is involved in the 
regulation of germline transcription via interaction with pol II CTD kinase, but not 
essential for transcriptional repression. One possible explanation is that 
maternally loaded epigenetic information to which PIE-1 SUMOylation 
contributes in the adult germline gives rise to a selectively limited transcription for 
germline specification and the YAPMAPT motif of PIE-1 interacts with CDK-12 
and/or other pol II binding partners to ensure transcriptional inhibition in the 
germline blastomere. Consistent with this possibility, although we tried to 
generate a pie-1 CRISPR strain containing both K68R and DAQMEQT by 
introducing the DAQMEQT sequence to the K68R mutant animals, a 
heterozygous DAQMEQT allele already caused embryonic lethality in the K68R 
homozygotes. 
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CHAPTER IV: DISCUSSION 
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The goal of this research was to understand how PIE-1 functions in germline 
specification. The Co-CRISPR strategy described in chapter I allowed us to 
generate all animal models with the desired alleles for this research. Because the 
genes of interest were modified by the CRISPR-Cas9 system at their 
endogenous loci, this research using the CRISPR lines could more accurately 
reflect the real biological situation, compared to using conventional transgenic 
approaches. For example, we demonstrated the nuclear localization of PIE-1 in 
the oocytes and meiotic germ cells of the pie-1::gfp CRISPR lines, while the 
previous transgenic lines did not show PIE-1 expression in the nuclei of adult 
germ cells (Reese et al., 2000). The first detection of PIE-1 localization in the 
adult germline was the crucial step in gaining new insight into how PIE-1 
functions in protecting germline integrity for gamete production. In chapter II, we 
determined the molecular mechanism by which PIE-1 plays a role in germline 
integrity. We showed that PIE-1 is SUMOylated in the adult germline, and its 
SUMOylation facilitates both HDA-1 SUMOylation and NuRD complex formation. 
Furthermore, the loss of PIE-1 SUMOylation results in increased levels of histone 
acetylation. Taken together, our results presented in chapter II suggest that PIE-
1 SUMOylation is important for preserving a NuRD complex-mediated proper 
epigenetic state in the adult germ line, which may affect germline integrity. 
However, we still do not have a clear answer as to how PIE-1 regulates 
transcription to maintain germline fate in the early embryos. 
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A Role for the YAPMAPT sequence in Transcriptional Regulation 
PIE-1 inhibits both Ser2 phosphorylation and Ser5 phosphorylation of pol II CTD 
(Seydoux and Dunn, 1997), which results in repression of pol II elongation and 
pol II initiation, respectively. Previously, a model was suggested in which PIE-1 
inhibits CTD Ser2 phosphorylation of Pol II by sequestering p-TEFb using the 
CTD-like motif YAPMAPT (Batchelder et al., 1999; Ghosh and Seydoux, 2008). 
In an effort to confirm this previous model, we generated and characterized the 
YAPMAPT mutant, pie-1(DAQMEQT) CRISPR strains, in the experiments 
presented in chapter III. Although the pie-1(DAQMEQT) homozygotes produced 
many sterile progenies and no dead embryos were found, the pie-
1(DAQMEQT)/pie-1(zu154) strain, which has one copy of pie-1(DAQMEQT) and 
one copy of pie-1 null allele, gave rise to all dead embryos with the pie-1 mutant 
phenotype. Thus, one functional copy of the pie-1 gene is enough for viability 
similar to that for wild-type animals. In addition, as discussed in chapter III, one 
copy of the pie-1(DAQMEQT) allele also caused embryonic lethality in the K68R 
homozygotes when we introduced the DAQMEQT sequence to the K68R mutant 
animals via the CRISPR-Cas9 system. These results imply that the YAPMAPT 
sequence may be a partially redundant with the K68R and/or other functional pie-
1 alleles. 
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PIE-1 Cleavage Event 
The molecular mechanisms that determine how PIE-1 regulates CTD Ser5 
phosphorylation of pol II still remain to be studied. The state of epigenetic marks 
that are maternally loaded during gamete production can be a crucial setting for 
the dynamic interplay among many components that inhibits or activates pol II. 
Consistent with this idea, PIE-1 is expressed and SUMOylated in the adult 
germline cells before fertilization. Perhaps, the PIE-1 SUMOylation may be 
required for inhibiting pol II initiation complex (PIC) formation by recruiting 
cofactors involved in epigenetic regulation. In an attempt to test these 
possibilities, we performed IP-multidimensional protein identification technology  
(MuDPIT, a mass spectrometry-based approach) proteomics on PIE-1. A C-
terminal GFP fusion PIE-1 was purified using GBP beads that had been 
previously used to successfully purify other GFP fusions proteins including MEP-
1 (in chapter II), UBC-9, and CDK-12. We found that PIE-1 solubility was 
markedly lower in IP buffer (see the Materials and Methods section in chapter II) 
than that of other proteins. Most purified PIE-1 protein from the soluble PIE-1 in 
the IP buffer, unexpectedly, was cleaved on the C-terminal region of PIE-1. We 
further investigated the exact cleavage site by mass spectrometry-based 
proteomics and found that the serine 327 residue is cleaved by AC3.5 (in 
collaboration with Shan Lu, National Institute of Biological Sciences, Beijing, 
China), which is predicted to have metallopeptidase activity based on protein 
domain information (http://www.wormbase.org, release WS264, date 08 march 
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2018). We next substituted the serine residue with alanine using CRISPR/Cas9-
mediated genome editing and examined whether the S327A mutation abolished 
PIE-1 cleavage. Indeed, the cleavage event was completely absent in the S327A 
mutant. Interestingly, we found that both K68R mutation and depletion of SMO-1 
by RNAi reduced the PIE-1 cleavage event somehow. Perhaps, the proteolytic 
cleavage event also can be regulated by PIE-1 SUMOylation. It will be interesting 
in the future to determine the functional consequence of the PIE cleavage event.  
 
MEP-1/NuRD Function in Maintaining Germline–Soma Distinction 
MEP-1 was previously identified as a PIE-1 interactor in a yeast two-hybrid 
screen (Unhavaithaya et al., 2002). Consistent with this result, we also found that 
MEP-1 interacts with PIE-1 in a yeast two-hybrid screen described in chapter II.  
Depletion of MEP-1 by RNAi induces a L1 larval arrest phenotype in which PGL-
1 protein is ectopically expressed in the somatic cells (Unhavaithaya et al., 
2002). Somatic expression of PIE-1 using the heat-shock promoter causes 
ectopic expression of PGL-1 in the intestinal cells, which mimics mep-1 loss of 
function (Unhavaithaya et al., 2002). Based on these results, PIE-1 was 
proposed to antagonize MEP-1 function (Unhavaithaya et al., 2002). However, 
the hsp::pie-1 transgenic strain does not induce significant transcriptional 
repression under conditions that inhibit MEP-1 (Unhavaithaya et al., 2002). It is 
not clear if the conditions are below the threshold for transcriptional repression 
(Unhavaithaya et al., 2002), because the overexpressed PIE-1 in the engineered 
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strain expressing a single-copy hsp::pie-1 (Frokjaer-Jensen et al., 2008) did not 
repress both MEP-1 and transcription. As discussed in chapter II, the previous 
finding that hsp::pie-1 mimics mep-1 loss of function (Unhavaithaya et al., 2002) 
may have been obtained due to an unexpected disruption of a functional gene by 
randomly integrated extrachromosomal array hsp::pie-1 in the genome. 
Alternatively, PIE-1 inhibits transcription, perhaps at specific loci, but not globally, 
given that somatic expression of PIE-1 in the pie-1(R109L)::gfp strain did not 
impair embryogenesis at all as discussed in chapter III. 
In chapter II, we showed that SUMOylation is required for PIE-1 function in 
germline specification. Consistent with a previous study (Wu et al., 2012), we 
detected ectopic expression of PGL-1 protein in the intestinal cells of pgl-
1::mCherry CRISPR lines when we depleted SMO-1 by RNAi. The genetic 
double strain pgl-1::mCherry, ubc-9(G56R) also showed ectopic PGL-1 
expression in somatic cells at 25°C. Like PGL-1::mCherry, both GFP::PRG-1 and 
GFP::CSR-1 were also ectopically expressed in somatic cells when either SMO-1 
or UBC-9 was depleted. These data suggest that SUMOylation is required to 
inhibit the expression of germline genes in somatic cells. Therefore, consistent 
with our results in chapter II, SUMOylation may facilitate NuRD complex-
mediated chromatin remodeling for a proper epigenetic state that is important for 
germline–soma distinctions. It will be interesting to investigate whether the MEP-
1–NuRD complex functions as a general repressor in both somatic and germline 
cells to protect their cell fate. Perhaps, PIE-1 and a key determinant of somatic 
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cell fate may recruit the MEP-1–NuRD complex to specific loci to define patterns 
of gene expression for germline specification and somatic specification, 
respectively. 
 
Functional Domains of PIE-1 
Two separate zinc-finger domains of PIE-1 contribute to asymmetric segregation 
of PIE-1 with the germline lineage (Figure 4.1) (Reese et al., 2000). ZF1 is 
targeted by ZIF-1, which interacts with the E3 ubiquitin ligase and promotes PIE-
1 degradation in somatic blastomeres (DeRenzo et al., 2003), while ZF2 targets 
PIE-1 to P-granules that are actively transported into the presumptive germ cell 
after cell division (Reese et al., 2000). The YAPMAPT sequence of the C-
terminal proline-rich region of PIE-1 is involved in transcriptional repression 
(Figure 4.1) (Batchelder et al., 1999). Interestingly, the proline-rich region is both 
sufficient and necessary for PIE-1 to interact with MEP-1 (Figure 4.1) 
(Unhavaithaya et al., 2002). In this research, we determined additional functional 
residues: K68 is required for PIE-1 SUMOylation, R109 on ZF1 is the target site 
of ZIF-1, and S327 is responsible for a PIE-1 cleavage event (Figure 4.1). 
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Figure 4.1 Functional domains of PIE-1 
ZF1 (amino acids 97–132) is required for degradation by ZIF-1 in somatic blastomere, 
and ZF2 (amino acids 180–217) associates with P granules. The proline-rich region 
(amino acids 240–335) is important for transcriptional repression and interaction with 
MEP-1. The red bar represents the consensus SUMO acceptor site of PIE-1. The blue 
line indicates R109 residue that is the target site of ZIF-1. The green line indicates the 
cleavage site, S327.  
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Conclusions 
Both the functional domains summarized in Figure 4.1 and our findings from this 
research (Figure 4.2) imply that PIE-1 is likely a multi-functional protein that 
regulates epigenetic modification, transcription, and post-transcriptional 
modification. However, the absence of a PIE-1 homolog in another organism 
makes the function of PIE-1 unpredictable. In addition, a certain threshold 
requirement for PIE-1 function (Batchelder et al., 1999; Tenenhaus et al., 1998; 
Unhavaithaya et al., 2002) (discussed in chapters II and IV) makes PIE-1 studies 
more complicated and challenging. Fortunately, efficient genome editing using 
CRIPSR-Cas9 technology allows us to explore the underlying molecular 
mechanisms more accurately and rapidly. In vivo SUMO purification from the 
various CRISPR strains that we employed here provides a powerful tool for 
exploring the function of genes of interest that are predicted to be SUMOylated. 
Using these major approaches, we have shown here that SUMOylation facilitates 
PIE-1–dependent germline maintenance and specification. PIE-1 SUMOylation is 
required for not only the formation of the NuRD complex but also for the 
promotion of other unsolved biological functions that are discussed in this 
chapter (Figure 4.2). Although the functional consequences and molecular 
mechanisms remain to be further elucidated, it is likely that SUMOylation acts as 
a switch to connect or disconnect many different functions of PIE-1 in a cell fate-
dependent manner or a developmental timing-dependent manner for the 
differentiation of germline cells and specialized somatic cells. 
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Figure 4.2 Schematic representation of the multiple-function of PIE-1 
1. SUMOylation is required for PIE-1 function in germline specification (red). 2.	A	role	for	the	YAPMAPT	sequence	in	transcriptional	regulation	(purple).	3. PIE-1 cleavage event 
(blue).  4. MEP-1/NuRD function in maintaining germline-soma distinction (green). 
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